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This thesis focuses on combinatorial synthesis of derivatives of bioactive compounds 
via a sulfone scaffold. 
 
The first project is to extend the application of polymer-supported sodium 
benzenesulfinate in solid-phase synthesis. A traceless solid-phase synthesis of 
trisubstituted and disubstituted 1,2,3-triazoles has been developed. 23 different 
compounds were obtained by [3+2] cycloaddition of the polymer-supported vinyl 
sulfones and sodium azide in 37-78% yield.  Using microwave irradiation, the total 
reaction time could be shortened from over 1 day to 1 h.  
 
The second project is to develop combinatorial synthesis of 
triazolo[4,5-b]pyridin-5-ones and pyrrolo[3,4-b]pyridin-2-ones. 22 
triazolo[4,5-b]pyridin-5-ones were prepared by  [3+2] cycloaddition of heterocyclic 
vinyl sulfones and azides in good yield (76% to 98%).  10 
pyrrolo[3,4-b]pyridin-2-ones were synthesized by [3+2] cycloaddition of heterocylic 
vinyl sulfones and isocyanides in good yield and regioselectivity. 
 
The third project aims to develop soluble polymer-supported Davis reagent and its 
application in organic synthesis. An efficient synthetic route of synthesizing 
polymer-supported Davis reagent was devised. The reagent was successfully applied 
vi 
in the oxidation of the sulfides, amines, selenides, phosphines and enolates as well as 
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Chapter 1 
Chapter 1             Introduction 
 
1.1 Combinatorial Chemistry 
Finding a novel drug is a complex process. Historically, the main source of 
biologically active compounds used in drug discovery programs has been natural 
products, isolated from plants, animals or fermentation sources. 
 
Combinatorial chemistry is one of the important new methodologies developed by 
researchers in the pharmaceutical industry to reduce the time and costs associated 
with producing effective and competitive new drugs. By accelerating the process of 
chemical synthesis, this method could have a profound effect on all branches of 
chemistry, especially on drug discovery. Through the rapidly evolving technology of 
combinatorial chemistry, it is now possible to produce compound libraries to screen 
for novel bioactivities. This powerful new technology has begun to help 
pharmaceutical companies to find new drug candidates quickly, save significant 
amount of money in preclinical development costs and ultimately change their 
fundamental approach to drug discovery. However, it is not only the drug discovery 
process that might benefit from the combinatorial chemistry, as the principles are 
being applied increasingly in the search for new materials1, 2 and better catalysts3-9. 
 
Combinatorial chemistry is a technique by which large numbers of structurally 
distinct molecules may be synthesized in a time and submitted for pharmacological 
assay. The key of combinatorial chemistry is that a large range of analogues are 
synthesized using the same reaction conditions and the same reaction vessels. In this 
way, the chemist can synthesize many hundreds or thousands of compounds in one 
1 
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time instead of preparing only a few by simple methodology. Figure 1.1 shows the 
difference between traditional synthesis and combinatorial synthesis. 
A + AB A1-m B1-n+ AiBj
Traditional Synthesis Combinatorial Synthesis
B
 
Figure 1.1 Difference between traditional synthesis and combinatorial chemistry 
 
For example, in the traditional approach, compound A would have been reacted with 
compound B to give AB, which in turn would be isolated and purified. In contrast to 
this approach, combinatorial chemistry offers the opportunity to synthesize every 
combination of compounds A1 to Am with compounds B1 to Bn, thus providing 
compounds AiBj (where i=1-m, j=1-n). This collection of compounds is referred to as 
a combinatorial library. In addition, because combinatorial synthesis discards the 
traditional concepts of organic synthesis that all compounds and intermediates need to 
be fully purified and characterized,   combinatorial synthesis is much faster and more 
economical.  
 
Generally, two different strategies are used in combinatorial synthesis: plit-pool 
synthesis and parallel synthesis.  
1.   Split-pool synthesis was introduced by Furka in 199110. Figure 1.2 shows a 
simple example of a preparation of a small library using this strategy. The 
starting resins are split into 3 portions and reacted with the first set of reagents 
(A1-A3). After the reaction, the resulting resins are mixed thoroughly and the 
mixture is split into 5 portions, each consisting of 3 compounds. After the 
reaction with the second set of reagents (B1-B5), a library of 15 different 
compounds is obtained. The resulting resins are mixed thoroughly and the 
2 
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mixture is split into 4 portions, each consisting of 15 compounds. After the 
reaction with the third set of reagents (C1-C4), a library of 60 different 
compounds is obtained. The primary advantage of this method is that very large 
assemblies of compounds can be synthesized by virtue of an exponential growth 
of compound number with synthetic reaction steps. Through this process, each 
resin bead in a library ends up (ideally) just one single compound bound to it. 
Combinatorial libraries resulting from split-pool synthesis are referred to as 
‘one-bead-one-compound’ libraries. Since the resulting compounds of this 
method are mixture, methods have to be developed for identifying the 
biologically active components from the mixture. Three approaches are 
generally used for the structural deconvolution of bioactive compounds from 
assay data: iterative deconvolution11, position scanning deconvolution method12 
and tagging13. 
 
2.  Combinatorial libraries can also be prepared by parallel synthesis14. Here, 
compounds are synthesized in parallel using ordered arrays of spatially separated 
reaction vessels adhering to traditional ‘one vessel-one compound’ philosophy 
(Figure 1.3). This offers the advantage that each compound, when evaluated for 
some desired performance, is substantially ‘pure’ in its local area, provided that 
the synthesis has proceeded with high efficiency in each stage. Furthermore, in 
parallel synthesis the defined location of compound in the array provides the 
structure of the compound. In general, combinatorial libraries comprising of 
hundreds to thousands of compounds are synthesized by parallel synthesis, often 
in an automated fashion. Unlike split-pool synthesis, which requires a solid- 


















































































































Figure 1.2 Split-pool synthesis (Sphere represent resin beads, A, B, C, represent 








Couple A 2 Reactions
2 Products
Couple B 4 Reactions
4 Products
A1B1 A1B1 A1B2 A1B2
A2B1 A2B1 A2B2 A2B2
Couple C 8 Reactions
8 Products
A1B1C1 A1B1C2 A1B2C1 A1B2C2
A2B1C1 A2B1C2 A2B2C1 A2B2C2  
Figure 1.3 Parallel synthesis (Sphere represent resin beads, A, B, C, represent the 
sets of building blocks, borders represent the reaction vessels.) 
 
In principle, combinatorial synthesis can be performed both in solution (solution 
phase) and on a solid support (solid-phase). Although chemistry in solution has the 
advantage of being familiar and well-established as the method of choice in 
conventional organic synthesis, to date the majority of the compound libraries have 
been synthesized on solid-phase. This may be attributed to five striking advantages of 
solid-phase chemistry over solution phase chemistry: 
1. The reactions can be accelerated and driven to completion by using a 
relatively large excess of reagents, resulting in reduced reaction time and 
higher yields. 
2. Separation and purification are simplified. For each step of multiple-step 
synthesis, the only purification needed is a resin-washing step. Only the final 
product obtained after cleavage from the solid support needs to be purified. 
5 
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3. Synthesis automation is enabled. The robots can do all the operations 
included in solid-phase synthesis, such as adding reagents, filtration, washing 
the resin, compounds isolation and analysis. 
4. It is more environmental friendly, as the toxic compounds bound to the solid 
support can be handled easily without risk to the users or the environment. 
5. Solid-phase reaction also facilitates the partitioning of compounds into 
multiple aliquots in the case of split-pool synthesis. 
 
However, solid-phase synthesis also has some limitations: 
1. Wastage of chemicals and solvents. In each reaction step, excess reagents are 
needed to drive the heterogeneous reaction and a large amount of solvents is 
needed for washing the resins. 
2. Effects of the support on the reaction need to be considered. These include: i) 
interactions with the support itself must be avoided; ii) a good resin swelling 
solvent is needed; iii) extremely low and high temperature conditions are 
discouraged; iv) concentrated reagent solutions are required to enhance coupling 
with the support and v) heterogeneous catalyst cannot be used. 
3. In many cases, two extra steps must be employed in the synthetic protocol: 
coupling the starting material onto the solid-phase and cleavage of the product 
from the solid-phase. 
4. Reactions on solid-phase cannot be monitored by simple and effective methods, 
such as TLC, GC or HPLC. Intermediates and final products can only be 
monitored by sophisticated on-bead methods or after cleavage of the product. 
5. The scale of solid-phase synthesis is limited and generally restricted by the 
amount of the solid support and its loading capacity. 
6 
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1.2 Solid-phase Synthesis 
Solid-phase synthesis really began in 1963, when Merrifield15 used polystyrene resin 
beads to aid the synthesis of peptides. This was followed in the 1970s and afterwards 
by investigations on solid-phase synthesis towards organic compounds by Leznoff , 
Camps, Frechet, Rapaport and others16-18. This shift in focus from peptide to non-
peptide libraries is attributed to: i) the character of the peptide backbone limits the 
structural diversity of peptides; ii) peptides have poor oral bioavailability and 
susceptibility to protease degradation; and iii) non-peptide compounds are structurally 
and chemically diverse and some have been shown to possess interesting bioactivities.  
 
In solid-phase synthesis, starting material A is covalently bound to a polymeric 
support via a linker molecule (Figure 1.4). The support most frequently used consists 
of cross-linked polystyrene in the form of small beads (diameter about 80-200 μm), 











Figure 1.4 Solid-phase synthesis 
 
Solid-phase bound A is reacted with another dissolved reagent B under appropriate 
conditions. Subsequent reactions are carried out in an analogous manner. In this way 
the molecule to be synthesized is assembled step by step on the polymeric support. 
After the synthesis, the product is liberated by cleaving it off the support. The exact 
7 
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conditions under which this is done depend on the structure of the linker. The product 
is then available for testing in biological assays. 
 
1.3 Solid Support 
Polystyrene cross-linked with 2% divinylbenzene (DVB) is the first generation solid 
support in organic synthesis, which was introduced by Merrifield15 in 1963.  This 
insoluble support has a gel-type structure which readily allows penetration of reagents 
and solvents into the sites in the beads where the chemistry takes place. The 
physicochemical properties of the resin depend heavily on the degree of the cross-
linking on the styrene.  Higher cross-linking degree gives better mechanical stability 
and thermal stability, but poorer swelling property and lower loading capacity, and 
vice versa. A general consensus now seems to have been reached, and typical 
supports used for solid-phase synthesis consist of polystyrene with a 1-2% DVB 
cross-linking (Figure 1.5).  This kind of polymer is able to swell in CH2Cl2, THF, and 
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The three dominant polystyrene supports currently in use are as follows. 
1. Chloromethylpolystyrene19.  It is also known as Merrifield resin. Originally 
prepared by resin derivatization using chloromethylmethyl ether and SnCl4, it 
has been more recently prepared by copolymerization using 
chloromethylstyrene/styrene/ DVB mixtures. This core resin is used widely for 
the attachment of linkers by ether formation. 
2. Wang resin. This resin was prepared from Merrifield resin by esterification 
with potassium acetate followed by saponification or reduction of the ester20.  
3. Aminomethylpolystyrene. This resin was prepared by Mitchell21 either by 
potassium phthalimide substitution of the Merrifield resin followed by 
hydrazinolysis or by direct aminomethylation of the polystyrene resin. 
Aminomethyl resin allows a multitude of spacers/ linkers to be appended to 
the resin by amide bonds, which are stable under strongly acidic conditions. 
This resin is useful as base resin for derivatization by acylation with 
carboxylic acid-containing linkers22. 
Although polystyrene is presently the most used support material in solid-phase 
synthesis, it has some limitations. 1) Hydrophobic property of polystyrene limits the 
swelling ability in the polar solvent, such as water and methanol.  2) The possibility of 
site-site interactions between molecules in the beads is also a concern during solid-
phase synthesis, especially in peptide synthesis23.  3) The thermal stability of the 
polystyrene limits the reaction temperature under 130 oC. Therefore a number of other 
materials have been developed for solid-phase synthesis. 
 
Polyamide polymer24, 25 is also known as Sheppard’s resin. The first generation of 
polyamide resin was copolymerized by N,N’-dimethylacrylamide, N-acryloyl-N’-Boc-
9 
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β-alaninylhexamethylenediamine and N,N’-bisacryloyethylenediamine (Figure 1.6). 
This kind of polymer more closely mimic the properties of peptide chains, thus it is 
widely used in peptide synthesis. This resin swells in polar solvents and aprotic 
solvents but has limited swelling ability in less polar solvent (e.g. CH2Cl2). In addition, 
its low mechanical stability makes handling difficult and its high cost precludes large-
scale use. To improve the physicochemical properties, various polyamide supports 
have been developed.  Replacing the  N,N’-dimethylacrylamide with more lipophilic 
N-acryloyl pyrrolidine produces a polymer that swells in solvent such as alcohols, 
acetic acid, and water which generally do not swell polystyrene sufficiently for 
synthesis. In addition it also swells well in CH2Cl226.  By polymerizing the acrylamide 
moiety into macroporous inorganic (Kieselguhr) or organic (polystyrene) particles, 
the mechanical stability was increased. However, the loading of Kieselguhr-supported 
polyamide (< 0.1 mmol/g) is much lower than organic material supported polyamide 















backbone monomer with protected functional group  
Figure 1.6 The precursors used in the preparation of polyacrylamide resins 
 
Tentagel resin was originally synthesized by the polymerization of ethylene oxide on 
cross-linked polystyrene already derivatized with tetraethylene glycol to give 
polyethylene glycol chains27. It consists of polyethylene glycol attached to cross-
linked polystyrene through an ether link, and combines the benefits of the soluble 
10 
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polyethylene glycol support (Figure 1.7) with insolubility and handling characteristics 






Figure 1.7 TentaGel resin has a polyethylene glycol chain grafted onto a cross-
linked polystyrene backbone 
 
Optimized TentaGel grafted resins generally carry polyethylene glycol chains of 
about 3kDa in size, accounting for about 70-80% of the beads by weight. It is 
remarkable that the cross-linked polystyrene backbone is sufficiently flexible to 
accommodate the polyethylene glycol and flex further still to permit the synthesis of 
peptides or other organic molecules. However, it should be noted that in general, the 
loading density on TentaGel (0.25 mmol/g) is lower than that obtainable on the 
standard cross-linked polystyrene (usually in the range 0.5-1.2 mmol/g). 
 
Although organic polymers are the most widely used supports, they do not have 
enough thermal and mechanical stability to perform continuous flow synthesis. 
However, inorganic materials do not show such limitations. Controlled pore glass 
(CPG) is a rigid and glass-derived bead material. This kind of support is stable to 
aggressive reagents and extremes of pressure and temperature. It has been 







An important component in the solid-phase synthesis is the linker. It can be defined as 
a bifunctional molecule which, on the one hand can be irreversibly to the carrier phase 
(resin) and, on the other hand, offers a reversible binding site for the coupling of 
desired molecules so that further chemical reactions may be carried out29.  In the past 
15 years, more than 200 linkers have been developed to allow many multistep organic 
syntheses to be performed.  However, an ideal linker should fulfill a number of 
important criteria: 
1. it should be cheap and easily available; 
2. the attachment of the starting should be readily achieved with high yields; 
3. the linkers need to be adapted to the chemistry performed. 
4. it should be possible for the product to be released from the solid support with 
high efficiency when the synthesis is complete, and the cleavage method used 
should not introduce impurities that are difficult to remove. 
Linkers are generally classified based on their cleavage conditions. According to the 
release method, there are six major classes of linkers: 
 
A. Acid-Labile Linkers 
Acid-labile linkers are the most commonly used linkers in both peptide and 
combinatorial chemistry. Chemicals such as TFMSA, HF, HBr, TFA, PPTS, acetic 
acid and HFIP can be employed as cleavage reagents. The greatest part of acid-labile 
linkers can be subdivided into two categories. The first subgroup is characterized by 
an acid labile acetal group, which is obtained following addition of an alcohol to a 
2,3-dihydro-4H-pyran (Scheme 1.1)30, 31. The cleavage of this linker is achieved with 












Scheme 1.1 Loading and cleavage of tatrahydropropyranyl(THP) linker 
 
The second subgroup, which contains the largest number of acid-labile linkers, can be 
characterized by their ability to form stable cations. Typical members of this group 




Benzyl-cation Benzhydryl-cation Trityl-cation  
          Figure 1.8 Polymer bound cations after cleavage of the product via SN1 
reaction 
 
The desired acid lability of the anchor can be altered through the substitution of 
different aromatic substituents (eg. methoxy, amino, or hydroxyl groups) which 
increases the stability of the intermediate cation and therefore weaker acids can be 
used for cleavage. The fine-tuning of the reaction conditions of cleavage is depicted in 
Figure 1.9 where the benzyl linker is used as an example29, 31. One disadvantage of 
increased electron density is the concomitantly higher reactivity of the linkers and the 
subsequent danger of losing the product before the last synthesis step as a result of 





















Merrifield-Resin Cleavage with HF
Wang-Resin Cleavage with 95% TFA
SASRIN-Resin Cleavage with 1% TFA




Figure1.9 Dependence of the cleavage conditions on the aromatic substituents 
Besides the linkers mentioned above, other acid-labile linkers are: silicon linkers32, 
ketal linkers33, semicarbazone linkers34, aryltriazene linkers35, etc. 
 
B. Nucleophile- or Base- labile linkers 
Nucleophile- or base- labile linkers were introduced to overcome the sensitivity of the 
certain target molecules to the acid conditions imposed on the linker by the target’s 
synthetic scheme.  The cleavage mechanism is based on either on β-elimination 
(Figure 1.10) or nucleophilic displacement (Figure 1.11). Table 1.1 demonstrates 
some common nucleophile-labile linkers and their cleavage reagents. From a single 
linker structure and synthesis, different products can be generated with the use of the 
different cleavage reagents providing a further source of diversity (e.g. HMBA resin 











































(LiAlH4)40, 41  
Kaiser oxime resin 
(Amine, hydrazine)41 
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Figure 1.11 Aminolysis of ester linker 
 
C. Photocleavable linkers 
Photolysis is an attractive option for releasing the product from the solid supports. 
Since there are no chemical reagents involved, an additional step of removing the 
cleavage reagents is not required. The product with functional groups such as 
15 
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carboxylic acids, carboxyamides, amidines or hydroxyl, can be liberated by 
irradiation at λ= 320-365 nm. This technique has a very good advantage that the 
cleavage can be performed in the aqueous solution and the released products can be 
directly used in the biological assays.  There are two classes of photolabile linker 
widely used in the combinatorial synthesis. One is the o-nitrobenzyl-derived linker 
which is transformed into an o-nitrosobenzaldehyde unit resulting in the concomitant 
release of the combinatorial compounds (Scheme 1.2)44; the other one is the desyl-























Scheme 1.2 Cleavage of o-nitrobenzyl-derived linker 
 
D. Metal-assisted cleavage linkers 
 Two distinct approaches have been based on the metal-assisted solid-phase cleavage 
reactions either through the activation of olefins by transition metals or 
activation/polarization of carbon-heteroatom bonds by Lewis acids, often softening 
the cleavage condition. 
 
Nicolaou46 used metal-assisted cleavage linker to synthesize the precursor of (S)-
zearalenone by intramolecular Stille reaction (Scheme 1.3).  Treatment of this 
polymer-bound precursor with 10% Pd(PPh3)4 in toluene for 48 h at 100 °C gave (S)-
zearalenone in 54% overall yield. The main advantage is that the organotin byproduct 
remains attached to the support and the organic target molecule is virtually free of 




















Scheme 1.3 Matel-assisted cleavage linker 
E. Safety-Catch Linkers 
Some linkers are totally stable during the synthetic sequence and only become labile 
after a process known as activation, which increases the lability of the linker towards 
well-defined cleavage conditions. These linkers, known as safety-catch linkers47, are 
very popular and allow the support and release of many different functionalities. One 
example shown in Scheme 1.4, Kenner’s linker48 was stable in both basic and acidic 
conditions until the nitrogen atom was alkylated either by diazomethane or 
iodoacetonitrile. The activated linker can be cleaved with necleophiles such as 0.5 N 
NH3-dioxane or hydrazine-MeOH, 0.5N NaOH, releasing amides, hydrazide, or 



































Scheme 1.4 An example of safety-catch linker 
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F. Traceless Linkers 
Most of the linkers leave a residue attached to the cleaved molecules such as 
carboxylic acid group, amide or alcohol group. The presence of these appendages is 
acceptable if the final product embodies these functionalities. However complications 
may arise if these functionalities are redundant and affect the activities of the 
compound. The search for so-called traceless linkers, that is, the linkers that do not 
leave obvious residual functional group derived from the cleavage reaction, has 
recently become a major area of interest in solid-phase chemistry. These linkers are 
usually substituted with a hydrogen atom during the cleavage, but some alternative 
quenchers have also been used. Two examples of traceless linkers are shown in 



















Scheme 1.5 The silicon traceless linker48, 49 
SO2Na
BrCH2R1


















































Scheme 1.6 The sulfone traceless linker50 
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1.5  Monitoring of Solid-phase reactions 
Synthetic route development in combinatorial synthesis remains a great hurdle and 
time-limiting factor in most library contribution. Reaction development generally can 
take months, and the library synthesis likely takes only weeks. Normally, solid-phase 
reaction optimization on a few individual compounds is required before the library 
synthesis. The process of “cleave and analyze” the product is time-consuming, 
laborious, and destructive. Some synthetic intermediates are not even stable enough to 
cleave condition. Therefore on-bead analytical methods are ideal for monitoring the 
solid-phase reaction and various techniques have been developed. 
1. FT-IR and FT-Raman spectroscopy 
IR spectroscopy can provide some information of the functional groups. FTIR 
is widely used in on-bead method for the routine monitoring solid-phase 
reaction, because of its good sensitivity and speed. This analysis offers a lot of 
information required for the reaction optimization such as qualitative ‘yes-or-
no’ answers and quantitative percentage of conversion. 
2.  Gel-phase NMR 
The largest obstacle to NMR analysis of compounds on a resin is the broad 
line in solid state NMR spectra, particularly in proton spectra, which arise 
from restricted molecular motion and heterogeneity of the sample.  Gel-phase 
NMR, whereby the resin is allowed to swell in a solvent so as to provide the 
molecules with greater degree of motional freedom, narrows the NMR 
resonance to a limited extent and is thus practical only for nuclei with a large 





3. Magic angle spinning (MAS) NMR 
Proton spectra are crucial for the monitoring of reactions and in the structural 
elucidation.  The MAS NMR is used to reduce the NMR line widths.  The 
magic angle spinning at 2-5 kHz allows susceptibility-induced line boarding 
terms to average out, resulting in narrower line widths. However, proton 
spectra of resin are generally dominated by the resonances that come from the 
solid support. The resin resonance can be reduced by using solvent 
suppression techniques and the Carr-Purcell-Meiboom-Gill (CPMG) spinlock 
90o – (τ -180o - τ)n51. 
4. Titration is a common laboratory method of quantitative chemical analysis, 
especailly the acid-base titration. It was widely used to measure the loading of 
reactive group on the resin, such as -NH2, -COOH, ArOH, ArSO2H, and –SH. 
 
1.6  Sulfone chemistry 
The sulfone functional group (1-1) owes its name to its formal resemblance to the 
carbonyl group and is best represented as the resonance between two canonical forms 
(1-2) (Figure 1.12). This group is associated with a high degree of thermodynamic 
stability. It can also function as a proton acceptor. In other word, it possesses 
essentially basic properties. Three important properties of the sulfonyl group mainly 
determine the overall properties of organic sulfonyl compounds: nonenolisability of 
the sulfonyl group, its electron attracting effect, and the resultant negative charge on 















The sulfone group renders the hydrogen atoms attached to the α-carbon atoms acidic. 
So sulfonyl group plays an important role in both organic synthetic and 
pharmaceutical aspects.  
Various sulfone containing heterocycles have been shown to possess diversified 
bioactivities such as antibacterial, antimalarial, antihelmintic, antilepral, 
antineoplastic, antiinflammatory and antidiabetic acitivities52.  Compound 1-3 (Figure 
1.13) is an example of an organic sulfone compound which exhibits anticoccidial 
activity in chicken (Eimeria tenella) with an MIC (minimum inhibitory concentration) 










Figure 1.13 One example of organic sulfonyl compounds 
 
Furthermore, sulfone containing heterocyclic reagent is also important in organic 
synthesis, for example, N-sulfonyloxaziridines (synthesized by Davis in 1970s, also 
called Davis’ reagent). This reagent can be easily prepared by condensation of 
sulfonamide and aldehyde, followed by oxidation using 3-
chlorobenzenecarboperoxoic acid (m-CPBA). This reagent was initially used as an 
oxidant for converting sulfur to sulfoxide, and then for converting amine to amine 
oxide. However in recent times, it was shown that the Davis’ reagent could also be 
applied in the insertion of a hydroxyl group to the α-carbon atoms of carbonyl group53, 
54. The preparation and the application of Davis’ reagent are illustrated in Figure 1.14. 
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Because of its chemoselectivity and efficiency, Davis’ reagent is now a widely used 



































Figure 1.14 Preparation and the application of Davis reagent 
The use of sulfones, acting as an auxiliary group, is an important synthetic strategy, 
especially for making carbon-carbon double bonds. This functional group can modify 
the polarity of the molecule by acting as a leaving group or as an electron-
withdrawing group to stabilize carbanions. Due to this dual chemical behavior, 
sulfones have been called chemical chameleons. Nowadays there are several synthetic 
methodologies in which sulfones are involved as activating groups. In the last 30 
years, the use of sulfones as intermediates in total synthesis of many natural products 
became a classic strategy. After the required synthetic operation, the sulfone moiety 
can be exchanged by hydrogen (reductive desulfonation), an alkyl group (alkylative 
desulfonation), a carbonyl functionality (oxidative desulfonation), a nucleophile 
(nucleophilic displacement) or through a α,β-elimination or a sulfur dioxide excursion 
proces55. An example of the application of sulfone chemistry in total synthesis is 
described in Scheme 1.7 56. Heliannuol A, 1-10, was isolated from the extracts of 
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cultivated sunflowers. It is believed to be involved in the allelopathic action of 
sunflowers. Starting with sodium benzenesulfinate, unsaturated sulfone 1-5 was 
obtained. After hydogenation of 1-5, the double bond was reduced and the benzyl 
protecting group was removed to afford 1-6. After incorporation of the desired ester 
group, the ring closure reaction was accomplished by treating 1-7 with lithium 
bis(trimethylsilyl) amide (LiHMDS). After reduction of the carbonyl group, 
compound 1-9 was obtained, which afforded Heliannuol A, 1-10 via desulfonation 


































Scheme 1.7 An example of the application of sulfone in total synthesis. 
 
Because of the importance of solid supports and linkers in solid-phase synthesis, it is 
important for chemists to find more suitable solid supports and links to transfer 
solution reactions onto solid supports. Furthermore, sulfone chemistry plays a very 
important role in organic synthesis57 and many desulfonation methods have been well 
developed55, 58, 59. Therefore, sulfone has been developed as an important linker in 
combinatorial chemistry. This research has been carried out from the 1970s59-61, and 
23 
Chapter 1 
the applications of sulfone as a solid-phase linker for synthesis of small molecule 
have been reported by three other groups besides our group.   
 
The first report on using polymer supported sulfinate as solid support to synthesize 
small molecular libraries was reported by Huang and his coworkers. With this solid 
support they had initially prepared 4,5-substituted-1,2,3-triazoles62 and 2,5-
substituted-1,3,4-oxadiazoles63 (Figure 1.15). Recently, they have studied the 
























Q. Huang et al. Tetrahedron Lett. 2001, 42, 1973-1974 
Figure 1.15 Huang and his coworkers’ application of polymer supported sulfinate 
 
In 1997, Kurth and his coworkers published their first paper on the preparation of 
trisubstituted olefins (Figure 1.16) with polymer supported sulfinate resin65. Two 
years later, they published the use of the same linker for the preparation of a library of 
cyclobutylidenes66 (Figure 1.16). This was followed by the synthesis of libraries of 
4,5,6,7-tetrahydrisoindole derivatives67, isoxazolocyclobutanones, 
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isoxazolinocyclobutenones68, enones69, styrenes69 and 3,5-disubstituted cyclopet-2-
enones70 (Figure 1.16). 
R2
R1R2  































M. J. Kurth et al. J. Org. Chem. 2001, 67, 4387-4391 
Figure 1.16 Kurth and his coworkers’ application of polymer supported sulfinate 
 
Recently, Sheng and his coworkers used this linker to synthesize substituted 




























S. Sheng et al. Synth. Commun. 2007, 37, 119-127 
Figure 1.17 Sheng and his coworkers’ application of polymer supported sulfinate 
 
Our group has also made various contributions to the development of this linker. In 
2001-2005, we made a series of nitrogen-containing heterocycles using the sulfinate 




















Y. L. Lam et al. Org. Lett. 2003, 5, 1067-1069 



























































X=S, O  
Y. L. Lam et al. J. Comb. Chem. 2005, 7, 721-725 
Figure 1.18 Lam and coworkers’ application of polymer supported sulfinate 
 
1.7 Objectives of our studies 
Compared to sodium benzenesulfinate, applications of polymer supported sulfinate 
resin are still limited and largely unexplored. One of the purposes of this study is thus 
to widen the use of polymer supported sodium benzenesulfinate in solid-phase 
synthesis. As heterocyclic compounds have been demonstrated to have various 
biologically interesting properties, we decided to examine the solid-phase synthesis of 
this class of compounds using polymer-supported sulfinate as a traceless linker.  
Another purpose of our study is to develop polymer-supported Davis reagent and 
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Chapter 2 Traceless Solid-phase Synthesis of 1,2,3-Triazoles 
 
2.1 Introduction 
2.1.1 Importance of 1,2,3-triazoles 
1,2,3-Triazoles are useful targets in chemical synthesis as they have been associated 
with a wide variety of interesting properties. Members of this class of compound are 
known to possess α-lactamase inhibitory1, anti-HIV2, antimicrobial3, antiviral and 
antiepileptic4 activities. Figure 2.1 shows a 1,2,3-triazole, compound A, which has 
been shown to demonstrate antileukemic and antitumor activities5. The cytotoxic 
activity of compound A was tested on HL-60, a human myeloid cell, and a mouse 
lymphoma cell line. The compound killed 75% of the cells in 7 days when used at the 
concentration of 10 x 10-6 M. Other triazole derivatives have also found fruitful 
applications as light stabilizers, fluorescent whiteners, precursors of insecticides, 












Figure 2.1 An example of bioactive 1,2,3-triazole 
 
2.1.2 General synthetic methods in solution phase chemistry 
A variety of solution phase strategies for synthesizing 1,2,3-triazole compounds have 
been developed.  These reactions can be broadly classified into 3 categories. They are: 
A. 1,3-dipolar addition 
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The 1,3-dipolar cycloaddition of azides and alkynes is the traditional and 
extensively used method in the 1,2,3-triazole synthesis7-21 (Scheme 2.1). This 
method was firstly reported by Robinson18 in 1951. The efficiency of this process 
is dependent on the steric and electronic properties of the alkyne and the 
regioselectivities of these reactions are generally low with unsymmetrical alkynes 
giving regioisomeric mixtures of triazoles. However the latter problem has 
recently been addressed with the use of copper catalysts (e.g. CuI ) 14, 17, 19-21. 
Another limitation of this strategy is the explosive and toxic nature of some 









Scheme 2.1 The 1,3-dipolar cycloaddition of azides and alkynes 
 
B. [3+2] cycloaddition 
The [3+2] cycloaddition of sodium azide and alkene is an alternative approach to 
synthesize the 4,5-disubstituted-1,2,3-triazoles22-26 (Scheme 2.2). The efficiency 
of this reaction is dependent on the electronic density of the alkene and the 
property of the leaving group. Compared to 1,3-dipolar addition, sodium azide is 
less explosive than organozide and no metal is employed in the reaction.  
However, only alkenes attached to a good leaving group can be used and such 









R3: leaving group, eg. Ts, CN, NO2, X, AcO  
Scheme 2.2 [3+2] Cycloaddition of sodium azide and alkene 
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C. Diazo intermediate cyclization 
This strategy is widely used to prepare the 4,5-disubstituted-1,2,3-triazoles. In 
general, the diazo intermediate is generated by the primary amine 
diazotization (Scheme 2.3)27-29 or obtained by the Bamford-Stevens reaction30-















 Scheme 2.3 Diazo intermediate cyclization  
 
2.1.3 Solid-phase synthesis of 1,2,3-triazoles 
To our knowledge there are only four earlier reports33-36 on the traceless synthesis of 
1,2,3-triazoles. Two of these publications33, 34 reported the preparation of 1,2,3-
triazoles using 1,3-dipolar cycloaddition between an alkyne and an azide. However, 
the regioselectivities of these cycloaddition reactions varied dramatically, depending 
on the nature of the alkyne used. To address this deficiency, our group had recently 
reported36 a traceless and regiospecific solid-phase synthesis of substituted 1,2,3-
triazoles using the polystyrene-sulfonyl hydrazide resin  (Scheme 2.4). However due 






















































Scheme 2.4 Traceless solid-phase synthesis of 1,2,3-triazoles using sulfonyl 
hydrazide resin 
 
Vinyl sulfones have now become generally accepted as useful intermediates in 
organic synthesis. Vinyl sulfones serve efficiently as both Michael acceptors and 2π 
partners in cycloaddition. There are two main methods in synthesizing vinyl sulfones 
(Scheme 2.5). They are: (1) Aldol, Wittig, Peterson and related reactions using 






















Scheme 2.5 Two main methods in synthesizing vinyl sulfones 
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The use of sodium benzenesulfinate 2-1 as a linker to form vinyl sulfones was firstly 
reported by the Huang’s group35. They had employed 2-1 and 2-bromoacetate to 
prepare ethyl polystyrylsulfonylacetate which subsequently underwent Knoevenagel 
condensation with substituted benzaldehydes to provide the solid-supported α-
sulfonyl-α-ester alkene 2-3. Treatment of 2-3 with NaN3 gave 5-phenyl-3H-




















Scheme 2.6 Traceless solid-phase synthesis of 1,2,3-triazoles using sodium 
benzenesulfinate resin 
 
In this project, we have extended the use of 2-1 to other derivatives of vinyl sulfones 
(Scheme 2.7). We have also demonstrated the application of I2/NEt3 for the 
preparation of vinyl sulfone on solid-phase format (Scheme 2.8). This has not been 
reported earlier. Treatment of the polymer-supported vinyl sulfones with NaN3 gave 
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Scheme 2.8 Traceless solid-phase synthesis of 1,2,3-triazoles using sodium 
benzenesulfinate resin 
 
2.2 Results and Discussion 
To define the scope of this reaction, representative triazoles were synthesized using  
2-1 to survey the requisite reaction conditions required for solid-phase synthesis. 
Treatment of 2-1 with bromoacetonitrile, α-bromoketone or α-bromoamide at 100 oC 
for 12 h gave 2-2 which was amenable to KBr FTIR monitoring (disappearance of the 
sulfinate stretch at 959 cm-1 and appearance of sulfone stretch at 1320 and 1147 cm-1, 
C=O stretch at 1746 cm-1 and CN stretch at 2258 cm-1). Subsequent Knoevanagel 
condensation of 2-2 with an aldehyde in refluxing benzene and 1 equiv piperidine as a 
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catalyst for 5 h35 gave the polymer-supported vinyl sulfone 2-3 which could not be 
reliably analyzed on the FTIR. Hence we proceeded with the cycloaddition of 2-3 
with NaN3 in DMF at 120 oC for 2 h (R1 = CN), 5 h (R1 = CO2CH3 or COCH3) or 12 h 
(R1 = CONH2) which concomitantly released the target molecule from the solid-
support in trace amounts. Attempts to carry out the condensation at higher 
temperatures led to the formation of various decomposition products. Further 
examination of the reaction indicated that the condensation occurred most favorable 
in refluxing THF for 36 h with piperidine or piperidine acetate as the catalyst. 
 
To facilitate combinatorial synthesis, we needed to establish a methodology to prepare 
the 1,2,3-triazoles more expediently. Since microwave irridiation has shown to 
provide striking reduction in reaction times and cleaner reactions over conventional 
thermal procedures37-39, we proceeded to explore the solid-phase synthesis of our 
compounds under microwave conditions. For the initial evaluation of the microwave-
assisted formation of 2-2, we carried out a systematic variation of the reaction time 
and temperature with bromoacetonitrile as a representative example. We discovered 
that the reaction was completed within 20 min at a preselected temperature of 60 oC 
and 10 equiv of bromoacetonitrile. Microwave-assisted Knoevanagel condensation of 
2-2 (R1 = CN) with benzaldehyde  in THF at 82 oC for 20 min followed by sodium 
azide cycloaddition at 120 oC for 20 min  under microwave activation (Table 2.1), 
extraction and purification gave 2-4a in 70% overall yield (versus 55% obtained via 




















Temp. (oC) reaction time overall yield (%) 
25 ≥ 48 h 64a 
25 20 min 32 
50 20 min 62 
80 20 min 65 
120 20 min 70 
150 20 min 63 
                                                 a without MW irradiation 
 
To illustrate the versatility of this methodology, a representative set of compounds (2-
4a – 2-4p) was prepared (Figure 2.2) and four of them were analyized by X-ray 
crystallography (Figure 2.3) .  Except for 2-4o and 2-4p (R1 = CONH2), the 
microwave-assisted procedure generally led to significantly higher conversion and 
purity. The lower yields for the amide-substituted triazoles may be attributed to the 
more sluggish Knoevanagel condensation which did not proceed at 82 oC. Hence 


































































2-4a  70% (55%) 2-4b  62% (43%) 2-4c  73% (42%) 2-4d  78% (40%)
2-4e  59% (33%) 2-4f  51% (31%)
2-4i  73% (58%)
2-4g  69% (41%) 2-4h  63% (51%)
2-4k  39% (12%) 2-4l  48% (24%)





2-4j  46% (35%)NO2
 
Figure 2.2 Library of 4,5-disubsituted-1,2,3-triazoles. The values in parentheses 











Figure 2.3 Crystal structures of 2-4b, 2-4c, 2-4f and 2-4i 
 
To address the regiochemistry of the cycloaddition reaction, resin 2-3a was treated in 
a one-pot coupling procedure with sodium azide and bromomethylcyclohexane (Table 




























Temp.  (oC) 2-3a:A:B:C yield (%)a
100 1:5:10:0 <5 
35 1:5:10:5 41 
70 1:5:10:5 45 
100 1:5:10:5 45 
120 1:5:10:5 50 
150 1:5:10:5 55 
                                                        a overall yield of 2-5a 
HMBC analysis of the major regioisomer 2-5a showed a proton-carbon correlation 
between the methylene proton (CH2C6H11) and the nitrile carbon indicating that the 
major isomer could possibly be the N1 and N2 regioisomer (Figure 2.4). Further 
analysis by X-ray crystallography confirmed that the major isomer is 2-
cyclohexylmethyl-5-phenyl-2H-[1,2,3]triazole-4-carbonitrile 2-5a (Figure 2.4). 
Analogous cycloadditions with various resin 2-3 and alkyl halides were also 
performed (Figure 2.5). The regioselectivity of each crude mixture was approximately 
10:1 with only polymer-bound 3-benzenesulfonyl-6-chloro-chromen-2-one and 
benzyl bromide providing a greater amount of the second regioisomer. Regiochemical 
assignments based on X-ray crystallography show that 2-5e1 and 2-5e2 are the major 






























































2-5e2  10%  
Figure 2.5 Trisubstituted-1,2,3-Triazoles 
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We have also examined the synthesis of 2-3 (R1 = H) via the ionic addition of 2-1 to 
alkenes (Scheme 2.8). To our knowledge this reaction has not been explored on solid-
phase. In our experiments, 2-1 was treated with styrene in the presence of I2 to yield 
β-iodosulfone 2-6 which was subsequently reacted with TEA to give the desired vinyl 
sulfone 2-3b. Microwave-assisted cycloaddition with sodium azide in DMF at 160 oC 
for 20 min gave 2-7a (R1 = C6H5)in 40% overall yield (cycloaddition at 120 oC for 20 
min gave 2-7a in 5% overall yield). Similarly, treatment of 2-1 with 1-methyl-4-vinyl-
benzene gave 2-7b (R2 = p-CH3C6H4)in 45% overall yield. 
 
2.3 Conclusions 
In this project, an efficient and regioselective traceless solid-phase synthesis of 
trisubstituted and disubstituted 1,2,3-triazoles has been devised. Using microwave 
irradiation, we have also shown that the total reaction time could be shortened from 
over 1 day to 1 h. Since a variety of reagents can be used in each step of the reaction, 
the overall strategy enables efficient library generation.  
 
2.4 Experimental section 
2.4.1 General procedures  
All experiments involving moisture or air sensitive were performed under N2 in 
flame-dried glassware capped with a rubber septum. Solid-phase reactions were 
agitated using a Flask shaker SF1 (Stuart Scientific). 
 
2.4.2 Materials 
Analytical grade chemical reagents were purchased from commercial suppliers 
(Aldrich, Fluka, Merck, TCI). The sodium benzenesulfinate resin was purchased from 
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Hecheng Co. of Nankai University. All of these compounds were used without further 
purification. Technical ethyl acetate and hexane were distilled before used. Other 
solvents are analytical grade and were used for washing and purification. 
 
2.4.3 Chromatography 
Analytical thin layer chromatography was performed using Merck Kieselgel 60 F254 
pre-coated silica gel glass plate. Visualization of the compounds on the silica gel glass 
plate was carried out by UV illumination and staining with iodine vapor, ninhydrin 
solution or phosphomolybdic acid hydrate solution. Flash column chromatograph was 
performed with silica (Merck, 70-230 mesh) under pressure. 
 
2.4.4 Physical data 
1H NMR and 13CNMR spectra were measured at ambient temperature on Bruker DPX 
300 or AMX 500 Fourier Transform spectrometer. Chemical shifts were reported in δ 
(ppm), relative to the internal standard of tetramethylsilane (TMS). And the signals 
observed were described as: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet) and br (broad). The number of protons (n) for a given resonance was 
indicated as nH. All Infra-red (IR) spectra were recorded on a Bio-Rad FTS 165 
spectrometer. Mass spectrometry was performed on a VG Micromass 7035 
spectrometer under EI, ESI or FAB. Crystallography data were collected at room 
temperature using a Siemens R3m/V diffractometer with Mo-Kα radiation (λ = 
0.71060 Å). Lorentz and polarization corrections, structure solution by direct methods, 
full-matrix least-squares refinements and preparation of figures were all performed by 
the SHELXTL-Plus PC program package. All non-hydrogen atoms were refined 
anisotropically whereas hydrogen atoms were placed at calculated positions with 
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isotropic displacement coefficient being assigned a value that is 1.6 times that of the 
atom to which it is attached.  
 
2.4.5 Experimental procedures 
Polymer-supported-2-(phenylsulfonyl)acetonitrile (2-2, R1 = CN) Resin 2-1 (0.952 
g, 2 mmol) was swollen in DMF (40 mL) for 30 min. Bromoacetonitrile (1.35 mL, 20 
mmol) was added and the mixture was heated at 60 oC under microwave irradiation 
(300 W) for 20 min. After which, the resin was filtered, washed with DMF (20 mL*2), 
H2O (20 mL*2), EtOH (20 mL*2), and CH2Cl2  (20 mL*2) and dried overnight at 50 
oC in a vacuum oven to give resin 2-2 (0.985 g). IR (KBr)/cm-1: 1142(νSO2), 
1338(νSO2), 2258(νCN). 
 
Polymer-supported-1-(phenylsulfonyl)propan-2-one (2-2, R1 = COCH3) Resin 2-1 
(0.952 g, 2 mmol) was swollen in DMF (40 mL) for 30 min. Chloroacetone (1.64 mL, 
20 mmol) was added and the mixture was heated at 60 oC under microwave irradiation 
(300 W) for 20 min. After which, the resin was filtered, washed with DMF (20 mL*2), 
H2O (20 mL*2), EtOH (20 mL*2), and CH2Cl2 (20 mL*2) and dried overnight at 50 
oC in a vacuum oven to give resin 2-2 (1.018 g). IR (KBr)/cm-1: 1149(νSO2), 
1319(νSO2), 1718(νC=O). 
 
Polymer-supported 2-(phenylsulfonyl)acetamide (2-2, R1 = CONH2) Resin 2-1 
(0.952 g, 2 mmol) was swollen in DMF (40 mL) for 30 min. Chloroacetamide (1.870 
g, 20 mmol) was added and the mixture was heated at 100 oC under microwave 
irradiation (300 W) for 20 min. After which, the resin was filtered, washed with DMF 
(20 mL*2), H2O (20 mL*2), EtOH (20 mL*2), and CH2Cl2 (20 mL*2) and dried 
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overnight at 50 oC in a vacuum oven to give resin 2-2 (1.019 g). IR (KBr)/cm-1: 1153 
(νSO2), 1327 (νSO2), 1746(νC=O). 
 
Polymer-supported-methyl 2-(phenylsulfonyl)acetate (2-2, R1 = CO2CH3) Resin 
2-1 (0.952 g, 2 mmol) was swollen in DMF (40 mL) for 30 min. Methyl 2-
bromoacetate (1.89 mL, 20 mmol), potassium iodide (3.320 g, 20 mmol) and 
tetrabutylammonium iodide (0.369 g, 1 mmol) were added and the mixture was 
heated at 60 oC under microwave irradiation (300 W) for 20 min. After which, the 
resin was filtered, washed with DMF (20 mL*2), H2O (20 mL*2), EtOH (20 mL*2), 
and CH2Cl2 (20 mL*2) and dried overnight at 50 oC in a vacuum oven to give resin 2-
2 (1.049 g). IR (KBr)/cm-1: 1156 (νSO2), 1327 (νSO2), 1745 (νC=O). 
 
Polymer-supported-1-(vinylsulfonyl)benzene (2-3)  
For resin 2-3 (R1 = CN, CO2CH3): Resin 2-2 (2 mmol) (R1 = CN, 0.985 g; R1 = 
CO2CH3, 1.049 g) was swollen in THF (40 mL) for 30 min. The respective aldehyde 
(20 mmol) and piperidine (0.20 mL, 2 mmol) were added and the mixture was heated 
to 82 oC under microwave irradiation (300 W) for 20 min. After which, the resin was 
filtered, washed with DMF (20 mL*2), H2O (20 mL*2), EtOH (20 mL*2), and 
CH2Cl2  (20mL*2) and dried overnight at 50 oC in a vacuum oven. 
 
For resin 2-3 (R1 = COCH3): Resin 2-2 (1.018 g, 2 mmol) was swollen in THF (40 
mL) for 30 min. The respective aldehyde (20 mmol), piperidine (0.20 mL, 2 mmol) 
and acetic acid (0.029 mL, 0.05 mmol) were added and the mixture was heated at 82 
oC under microwave irradiation (300 W) for 20 min. After which, the resin was 
49 
Chapter 2 
filtered, washed with DMF (20 mL*2), H2O (20 mL*2), EtOH (20 mL*2), and 
CH2Cl2 (20 mL*2) and dried overnight at 50 oC in a vacuum oven.  
 
For resin 2-3 (R1 = CONH2): Resin 2-2 (1.019 g, 2 mmol) was swollen in DMF (40 
mL) for 30 min. The respective aldehyde (20 mmol) and piperidine (0.20 mL, 2 mmol) 
were added and the mixture was heated at 111 oC under microwave irradiation (300 W) 
for 20 min. After which, the resin was filtered, washed with DMF (20 mL*2), H2O 
(20 mL*2), EtOH (20 mL*2), and CH2Cl2 (20 mL*2) and dried overnight at 50 oC in 
a vacuum oven. 
 
General Procedure for the Synthesis of Disubstituted 1,2,3-Triazoles (2-4). Resin 
2-3 (2 mmol) were swollen in DMF (40 mL) for 30 min. Sodium azide (0.650 g, 10 
mmol) was added to the mixture and then the mixture was heated at 120 oC under 
microwave irradiation (300 W) for 20 min. After which, the mixture was filtered, 
washed with DMF (20 mL*2) and H2O (20 mL*2). The mixture was concentrated by 
rotavapor and then extracted with ethyl acetate (20 mL*3) and pH = 2 brine. The 
combined organic layer was washed with brine (30 mL*2), dried with MgSO4, 
concentrated to dryness, and purified by column chromatography. Compound 2-4e 
was purified by recentralization from acetone. 
 
 5-Phenyl-2H-1,2,3-triazole-4-carbonitrile (2-4a). 0.238 g, yield: 70%. 1H NMR 
(DMSO-d6, 300MHz): δ 7.45-7.55 (m, 3H, ArH), 7.81-7.85 (m, 2H, ArH). 13C NMR 
(DMSO-d6, 75MHz): δ 113.4, 116.2, 125.8, 126.6, 129.4, 130.5, 148.3. HRMS (EI) 




5-Furan-2-yl-2H-[1,2,3]triazole-4-carbonitrile (2-4b) 0.198 g, yield: 62%. 1H NMR 
(DMSO-d6, 300MHz): δ 6.74-6.76 (dd, 1H, J = 1.8Hz, J = 3.4Hz, ArH), 7.09-7.11 (d, 
1H, J = 3.6Hz, ArH), 7.99-7.80 (d, 1H, J = 1.6Hz, , ArH). 13C NMR (DMSO-d6, 
75MHz): δ 111.3, 112.4, 112.5, 115.1, 138.6, 141.5, 145.1. HRMS (EI) calcd. for 
C7H4N4O: 160.0385; found: 160.0383. 
 
5-(Thiophen-2-yl)-2H-1,2,3-triazole-4-carbonitrile (2-4c). 0.256 g, yield: 73%. 1H 
NMR (DMSO-d6, 300MHz): δ 7.18-7.21 (dd, 1H, J = 3.8Hz, J = 4.9Hz, ArH), 7.63-
7.65 (d, 1H, J = 3.6Hz, ArH), 7.72-7.74 (d, 1H, J = 5.1Hz, ArH). 13C NMR (DMSO-
d6, 75MHz): δ 112.7, 115.2, 127.4, 127.7, 128.4, 129.3, 142.7. HRMS (EI) calcd. for 




5-(Pyridin-3-yl)-2H-1,2,3-triazole-4-carbonitrile (2-4d). 0.267 g, yield: 78%. 1H 
NMR (DMSO-d6, 300MHz): δ 7.63-7.68 (dd, 1H, J  = 5.0Hz, J = 8.1Hz, H on 
pyridine), 8.24-8.28 (dt, 1H, J = 2.3Hz, J = 3.9Hz, J = 8.0Hz , H on pyridine), 8.74-
8.76 (dd, 1H, J = 1.3Hz, J = 4.8Hz, H on pyridine). 9.07-9.08 (d, 1H, J = 2.3Hz, H on 
pyridine). 13C NMR (DMSO-d6, 75 MHz): δ 112.9, 116.8, 122.7, 124.3, 134.2, 144.8, 
147.2, 151.1. HRMS (EI): calcd. for C8H5N5: 171.0545; found: 171.0542. 
 
  5-(Pyridin-2-yl)-2H-1,2,3-triazole-4-carbonitrile (2-4e). 0.203 g, yield: 59%. 1H 
NMR (DMSO-d6, 300MHz): δ 7.52-7.57 (m, 1H, H on pyridine), 8.02-8.07 (m, 2H, H 
on pyridine), 8.75-8.77 (m, 1H, H on pyridine). 13C NMR (DMSO-d6, 75MHz): δ 
112.9, 117.5, 121.3, 125.1, 137.8, 145.7, 146.7, 149.9. HRMS (EI) calcd. for C8H5N5: 




5-Furan-2-yl-2H-[1,2,3]triazole-4-carboxylic acid methyl ester (2-4f). 0.198 g, 
yield: 51%. 1H NMR (DMSO-d6, 300MHz): δ 3.89 (s, 3H, CH3), 6.69-6.71 (dd, 1H, J 
= 1.8Hz, J = 3.4Hz, ArH), 7.39-7.40 (d, 1H, J = 3.4Hz, ArH), 7.91 (s, 1H, ArH). 13C 
NMR (DMSO-d6, 75MHz): δ 51.9, 112.1, 113.6, 132.0, 135.6, 142.6, 144.4, 161.1. 
HRMS (EI) calcd. for C8H7N3O3: 193.0487; found: 193.0486. 
 
8-Chloro-3H-5-oxa-1,2,3-triaza-cyclopenta[a]naphthalen-4-one (2-4g). 0.305 g, 
yield: 69%. 1H NMR (DMSO-d6, 300MHz): δ 7.59-7.8.07 (m, 3H, ArH). 13C NMR 
(DMSO-d6, 75MHz): δ 113.1, 119.3, 122.5, 128.8, 130.5, 131.1, 140.5, 150.7, 154.0. 
HRMS (EI) calcd. for C9H4ClN3O2: 220.9992; found: 220.9992. 
 
3H-5-Oxa-1,2,3-triaza-cyclopenta[a]naphthalen-4-one (2-4h). 0.234 g, yield: 63%. 
1H NMR (DMSO-d6, 300MHz): δ 7.50-7.58 (m, 2H, ArH), 7.65-7.71 (m, 1H, ArH), 
8.04-8.07 (m, 1H, ArH). 13C NMR (DMSO-d6, 75MHz): δ 111.3, 117.2, 123.4, 124.9, 
130.3, 131.5, 141.0, 152.1, 154.5. HRMS (EI) calcd. for C9H5N3O2: 187.0382; found: 
187.0382. 
 
5-Thiophen-2-yl-2H-[1,2,3]triazole-4-carboxylic acid methyl ester (2-4i). 0.305 g, 
yield: 73%. 1H NMR (DMSO-d6, 300MHz): δ 3.89 (s, 3H, CH3), 7.17-7.20 (dd, 1H, J 
= 3.8Hz, J = 4.9Hz, ArH), 7.70-7.72 (d, 1H, J = 4.5Hz, ArH), 7.96-7.97 (d, 1H, J = 
3.2Hz, ArH). 13C NMR (DMSO-d6, 75MHz): δ 52.0, 127.7, 128.4, 129.18, 129.9, 




5-(4-Nitro-phenyl)-2H-[1,2,3]triazole-4-carboxylic acid methyl ester (2-4j). 0.227 
g, yield: 46%. 1H NMR (DMSO-d6, 300MHz): δ 3.82 (s, 3H, CH3), 8.02-8.05 (d, 2H, 
J = 8.7Hz, ArH), 8.21-8.24 (d, 2H, J = 8.7Hz, ArH). 13C NMR (DMSO-d6, 75MHz): δ 
52.1, 123.2, 130.1, 133.6, 135.4, 144.5, 147.5, 160.9. HRMS (ESI) calcd. for [M-H] 
C10H7N4O4: 247.0467; found: 247.0457. 
 
1-(5-Phenyl-2H-1,2,3-triazol-4-yl)ethanone (2-4k). 0.145 g, yield: 39%. 1H NMR 
(DMSO-d6, 300MHz): δ 2.62 (s, 3H, CH3), 7.45-7.48 (m, 3H, ArH), 7.81-7.84 (m, 2H, 
ArH). 13C NMR (DMSO-d6, 75MHz): δ 28.4, 128.2, 128.9, 129.4, 141.2, 143.0, 143.2, 
192.6. HRMS (EI) calcd. for C10H9N3O: 187.0746; found: 187.0740. 
 
1-(5-(Furan-2-yl)-2H-1,2,3-triazol-4-yl)ethanone (2-4l). 0.171 g, yield: 48%. 1H 
NMR (DMSO-d6, 300MHz): δ 2.60 (s, 3H, CH3), 6.65-6.66 (dd, 1H, J = 1.8Hz, J 
=3.4Hz, ArH), 7.58-7.59 (dd, 1H, J = 0.7Hz, J = 3.4Hz, ArH), 7.87-7.88 (dd, 1H, J = 
0.7Hz, J = 1.6Hz, ArH). 13C NMR (DMSO-d6, 125Hz): δ 28.0, 112.0, 114.0, 140.1, 
142.4, 142.6, 144.8, 192.1. HRMS (EI) calcd. for C8H7N3O2: 177.0538; found: 
177.0539. 
 
1-(5-(Thiophen-2-yl)-2H-1,2,3-triazol-4-yl)ethanone (2-4m). 0.162 g, yield: 42%. 
1H NMR (DMSO-d6, 300MHz): δ 2.63 (s, 3H, CH3), 7.16-7.18 (dd, 1H, J = 3.8Hz, J = 
5.1Hz, ArH), 7.66-7.68 (dd, 1H, J = 1.2Hz, J = 5.1Hz, ArH), 8.09-8.10 (dd, 1H, J = 
1.1Hz, J = 3.6Hz, ArH). 13C NMR (DMSO-d6, 75MHz): δ 28.2, 127.6, 128.7, 129.4, 





1-(5-(Pyridin-3-yl)-2H-1,2,3-triazol-4-yl)ethanone (2-4n). 0.205 g, yield: 55%. 1H 
NMR (DMSO-d6, 300MHz): δ 2.57 (s, 3H, CH3), 7.83-7.88 (dd, 1H, J = 5.2Hz, J = 
7.4Hz, H on pyridine), 8.62-8.65 (dd, 1H, J = 1.5Hz, J = 8.0Hz, H on pyridine), 8.80-
8.82 (d, 1H, J = 5.3Hz, H on pyridine), 9.22 (s, 1H, H on pyridine). 13C NMR 
(DMSO-d6, 75MHz): δ 28.2, 125.6, 127.7, 141.0, 141.5, 142.2, 144.9, 145.5, 193.0. 
HRMS (EI) calcd. for C9H8N4O: 188.0698; found: 188.0692. 
 
5-Phenyl-2H-1,2,3-triazole-4-carboxamide (2-4o). 0.138 g, yield: 37%. 1H NMR 
(DMSO-d6, 300MHz): δ 7.36-7.50 (m, 4H, ArH + CONH), 7.85-7.92 (m, 3H, ArH + 
CONH). 13C NMR (DMSO-d6, 75MHz): δ 128.2, 128.5, 128.7, 128.9, 137.5, 142.2, 
162.8. HRMS (EI) calcd. for C9H8N4O: 188.0698; found: 188.0689. 
 
5-(Thiophen-2-yl)-2H-1,2,3-triazole-4-carboxamide (2-4p). 0.200 g, yield: 51%. 1H 
NMR (DMSO-d6, 300MHz): δ 7.12-7.15 (dd, 1H, J = 3.8Hz, J = 4.9Hz, ArH), 7.59-
7.61 (d, 2H, ArH + CONH), 7.94 (s, 1H, CONH), 8.12-8.13 (d, 1H, J = 3.2Hz, ArH). 
13C NMR (DMSO-d6, 75MHz): δ 127.7, 128.0, 129.2, 130.6, 136.4, 139.2, 162.7. 
HRMS (EI) calcd. for C7H6N4OS: 194.0262; found: 194.0265. 
 
General Procedure for the Synthesis of Trisubstituted 1,2,3-Triazoles (2-5). Resin 
3 (2 mmol) was swollen in DMF (40 mL) for 30 min. Sodium azide (0.650 g, 10 
mmol), alkyl bromide (20 mmol) and DiEA (1.74 mL, 10 mmol) were added to the 
mixture and then the mixture was heated to 150 oC under microwave irradiation (300 
W) for 20 min. After which, the resin was filtered and washed with DMF (20 mL*2), 
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H2O (20 mL*2). The mixture was concentrated on a rotavapor and then extracted with 
ethyl acetate (20 mL*3) and brine. The combined organic layer was washed with 
brine (30 mL*2), dried with MgSO4, concentrated to dryness, and purified by column 
chromatography. 
 
2-Cyclohexylmethyl-5-phenyl-2H-[1,2,3]triazole-4-carbonitrile (2-5a). 0.292 g, 
yield: 55%. 1H NMR (CDCl3, 300MHz ): δ 0.99-1.76 (m, 10H, CH2), 2.02-2.15 (m, 
1H, CH), 4.31-4.34 (d, 2H, J = 7.2Hz, CH2), 7.42-7.52 (m, 3H, ArH), 7.96-8.00 (m, 
2H, ArH). 13C NMR (CDCl3, 75MHz): δ 25.3, 25.9, 30.2, 38.2, 62.1, 112.7, 117.1, 
126.5, 127.6, 129.0, 129.9, 150.7. HRMS (EI) calcd. for C16H18N4: 266.1531; found: 
266.1526. 
 
2-Cyclohexylmethyl-5-pyridin-3-yl-2H-[1,2,3]triazole-4-carbonitrile (2-5b). 0.368 
g, yield: 69%. 1H NMR (CDCl3, 300MHz ): δ 0.96-1.73 (m, 10H, 5CH2), 2.00-2.12 (m, 
1H, CH), 4.32-4.34 (d, 2H, J = 7.0Hz, CH2), 7.39-7.43 (dd, 1H, J = 7.6Hz, J = 4.9Hz, 
H on pyridine), 8.23-8.26 (d, 1H, J = 8.0Hz, H on pyridine), 8.67 (br, 1H, H on 
pyridine ), 9.19 (br, 1H, H on pyridine). 13C NMR (CDCl3, 125MHz): δ 25.3, 25.8, 
30.2, 38.2,  62.3, 112.1, 117.5, 123.7, 123.9, 133.7, 147.5, 147.9, 150.6. HRMS (EI) 
calcd. for C15H17N5: 267.1484; found: 267.1474. 
 
2-Butyl-5-phenyl-2H-[1,2,3]triazole-4-carbonitrile (2-5c). 0.279 g, yield: 62%. 1H 
NMR (CDCl3, 300MHz): δ 0.95-1.00 (t, 3H, J = 7.3Hz, CH3), 1.32-1.44 (m, 2H, CH2), 
1.96-2.06 (m, 2H, CH2), 4.47-4.52 (t, 2H, J = 7.0Hz, CH2) 7.42-7.52 (m, 3H, ArH), 
7.96-7.99 (m, 2H, ArH). 13C NMR (CDCl3, 75MHz): δ 13.3, 19.5, 31.2, 55.9, 112.7, 
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117.1, 126.5, 127.6, 129.0, 129.9, 150.7. HRMS (EI) calcd. for C13H14N4: 226.1218; 
found: 226.1211. 
 
2-Butyl-5-pyridin-3-yl-2H-[1,2,3]triazole-4-carbonitrile (2-5d). 0.258 g, yield: 
57%. 1H NMR (CDCl3, 300MHz): δ 0.93-0.98 (t, J = 7.3Hz, 3H, CH3), 1.30-1.40 (m, 
2H, CH2), 1.95-2.05 (m, 2H, CH2), 4.49-4.54 (t, 2H, J = 7.3Hz, CH2), 7.40-7.44 (dd, 
1H, J = 7.3Hz, J = 4.9Hz, H on pyridine), 8.24-8.27 (d, 1H, J = 8.0Hz, H on pyridine), 
8.68 (br, 1H, H on pyridine ), 9.20 (br, 1H, H on pyridine). 13C NMR (CDCl3, 
125MHz): δ 13.2, 19.4, 31.1, 56.1, 112.1, 117.6, 123.7, 124.0, 133.7, 147.5, 147.9, 
150.6. HRMS (EI) calcd. for C12H13N5: 227.1171; found: 227.1168. 
 
2-Benzyl-8-chloro-2H-5-oxa-1,2,3-triaza-cyclopenta[a]naphthalen-4-one (2-5e1). 
0.312 g, yield: 50%. 1H NMR (CDCl3, 300MHz): δ 5.80 (s, 2H, CH2), 7.32-7.98 (m, 
8H, ArH). 13C NMR (CDCl3, 75MHz): δ 60.7, 114.5, 119.08, 123.0, 128.6, 129.0, 
129.1, 130.4, 131.0, 132.6, 133.2, 146.3, 151.1, 154.3. HRMS (EI) calcd. for 
C16H10ClN3O2: 311.0467; found: 311.0469. 
 
3-Benzyl-8-chloro-3H-5-oxa-1,2,3-triaza-cyclopenta[a]naphthalen-4-one (2-5e2). 
0.060 g, yield: 10%. 1H NMR (CDCl3, 300MHz): δ 5.99 (s, 2H, CH2), 7.32-8.22 (m, 
8H, ArH). 13C NMR (CDCl3, 75MHz): δ 53.9, 115.3, 118.72, 120.0, 122.7, 128.7, 
129.0 (2), 130.7, 131.1, 133.9, 147.3, 150.6, 152.4. HRMS (EI) calcd. for 




General Procedure for the Synthesis of Polymer-bound-Iodosulfone (2-6). Resin 
2-1 (0.952 g, 2 mmol) was swollen in CH2Cl2/MeOH (10 mL:10 mL) for 30 min. I2 
(2.538 g, 10 mmol) and styrene (10 mmol) were added and the mixture was shaken at 
rt for 12 h. After which, the resin was filtered and washed with DMF (20 mL*2), H2O 
(20 mL*2), EtOH (20 mL*2), and CH2Cl2  (20 mL*2) and dried overnight at 50 oC in 
a vacuum oven. 
 
General Procedure for the Synthesis of Polymer-bound Vinyl Sulfone (2-3b). 
Resin 2-6 (2 mmol) was swollen in CH2Cl2/CH3CN (10 mL: 10 mL) for 30 min. TEA 
(1.39 mL, 10 mmol) was added and the mixture was shaken at rt for 12 h. After which, 
the resin was filtered and washed with DMF (20 mL*2), H2O (20 mL*2), EtOH (20 
mL*2), and CH2Cl2  (20 mL*2) and dried overnight at 50 oC in a vacuum oven. 
 
General Procedure for the Synthesis of Monosubstituted 1,2,3-Triazoles (2-7). 
Resin 2-3b (2 mmol) was swollen in DMF (40 mL) for 30 min. Sodium azide (0.650 g, 
10 mmol) was added and then the mixture was heated at 160 oC under microwave 
irradiation (300 W) for 20 min. After which, the resin was filtered and washed with 
DMF (20 mL*2), H2O (20 mL*2). The mixture was concentrated on a rotavapor and 
then extracted with ethyl acetate (20 mL*3) and brine. The combined organic layer 
was washed with brine (30 mL*2), dried with MgSO4, concentrated to dryness, and 
purified by column chromatography. 
 
4-Phenyl-2H-[1,2,3]triazole (2-7a). 0.101 g, yield: 40%. 1H NMR (DMSO-d6, 
300MHz): δ 3.38 (br, 1H, NH), 7.32-7.48 (m, 3H, ArH), 7.84-7.88 (m, 2H, ArH), 8.33 
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(s, 1H, H on triazole ring). 13C NMR (DMSO-d6, 75MHz): δ 125.5, 127.2, 128.0, 
128.8, 130.3, 145.2. HRMS (EI) calcd. for C8H7N3: 145.0640; found: 145.0639. 
 
4-p-Tolyl-2H-[1,2,3]triazole (2-7b). 0.129 g, yield: 45%. 1H NMR (DMSO-d6, 
300MHz): δ 2.29 (s, 1H, CH3), 7.22-7.24 (d, 2H, J = 8.0Hz, ArH), 7.74-7.77 (d, 2H, J 
= 8.0Hz, ArH), 8.26 (s, 1H, H on triazole ring). 13C NMR (DMSO-d6, 75MHz): δ 20.8, 
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Dihydropyridinones 3-1 are a common occurrence in many pharmacological active 
substances of natural or synthetic origin1-5. They have been used in the treatment of 
chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial 
infarction and heart failure development2, 3 and have also been shown to possess 
hepatoprotective properties4. On the contrary, heterocyclic condensed 
dihydropyridinones are rarely studied with only a few reports on the syntheses and 
biological activities of pyrazolopyridinones 3-2 being published6-9. Our interest in the 
search of alternative drug structures by the isosteric replacement of atoms or groups 
led us to consider the triazole and pyrrole structures as possible alternatives to the 
pyrazole moiety in compound 3-2. Hence we herein describe the syntheses of 
triazolo[4,5-b]pyridin-5-ones 3-3 and pyrrolo[3,4-b]pyridin-2-ones 3-4 which, to our 


































3.2 Results and Discussion 
3.2.1 Synthesis of substituted triazolo[4,5-b]pyridin-5-ones 
1,2,3-Triazoles are an important type of heterocyclic compound because of their 
numerous applications in industry, medicine and agrochemicals10, 11. They are 
traditionally prepared via the 1,3-dipolar cycloaddition of an alkyne and azide. 
However, we have recently shown that 1,2,3-trizoles can be efficiently and 
regioselectively prepared via [3+2] cycloaddition of azides and vinyl sulfones 
(Chapter 2)12. To expand this study, we have investigated the reaction using 
heterocyclic vinyl sulfones and azides (Scheme 3.1). We reasoned that such a reaction 
would be attractive because many vinyl sulfones are easily prepared and thermally 
stable and would thus possess advantage over the original nitroolefins13-15. In addition, 
this methodology, unlike the other methods to synthesize 1,2,3-triazoles16-19, would 







2. R4Br, NBu4I, acetone,
reflux 12h; or
1. NaN3, DMF, 160oC, 48h







3-3(Yield: 76 - 98%)
R1 = Bn, Bu, CH2C4H3O; R2 = H, CH3; R3 = H, CH3, Ph, CH(CH3)2
R4 = H, Bu, Bn, CH2CN, CH2COPh, CH2CONHBu, CH2CO2CH3, CH2C6H11  
Scheme 3.1 [3+2] cycloaddition of heterocyclic vinyl sulfones and azides 
 
To begin our studies, 3,4-dihydro-5-sulfonylpyridin-2-ones 3-5 were prepared from 
N-substituted-2-(phenylsulfonyl)acetamide 3-7 and α,β-unsaturated esters according 




















































Scheme 3.2 Synthesis of 3,4-dihydro-5-sulfonylpyridin-2-ones 3-5 
 
With compound 3-5 in hand, we proceeded to explore the [3+2] cycloaddition 
reaction by initially treating N-benzyl-4-methyl-5-phenylsulfonyl-3,4-dihydropyridin-
2-one 3-5b with sodium azide (5 equiv) in DMF at 120 oC under microwave 
irradiation. The reaction was incomplete after 20 minutes and further irradiation up to 
3.5 hours did not result in the complete conversion of 3-5b. Hence various reaction 
conditions were studied (Table 3.1) and it was found that compound 3-3b could be 
obtained in quantitative yield when the reaction was carried out under conventional 




















Temp. Solvent Time Method Yield (%)a 
120 DMF 20 min MW 5b 
170 DMF 20 min MW 28b 
180 DMF 20 min MW 39b 
180 DMF 3.5 h MW 34b 
200 DMF 1.5 h MW 52c 
220 DMF 20 min MW 50c 
135 DMF 5 days reflux 61b 
135 DMSO 12 h reflux 50b 
160 DMF 2 days reflux 98 
180 DMSO 12 h reflux 28c 
                                     a purified yield 
                             b TLC showed an incomplete conversion of 3-5b 
                                           c TLC showed the presence of other side products 
 
With the solution phase pathway established, we attempted to apply the method to 
solid-phase synthesis (Scheme 3.3). However only trace amounts of product 3-3b 
were formed, this low yield may be attributed to the heterogeneous reaction between 
NaH and the resin in the annulation step. Therefore, we went back to the solution 
phase study of the annulation step.  Various soluble bases were used to synthesize 
compound 3-8a (Table 3.2).  We found n-BuLi gave the best yield at a lower 
temperature. However when we employed n-BuLi in the solid-phase synthesis of 3-3b, 
only 5% overall yield was obtained. This could possibly be due to poor swelling 















































Scheme 3.3 Solid-phase synthesis of 3-3b 
 















Entry Base Solvent Temp. Time Yield a 
1 NaH THF rt 12h 80% 
2 EtONa THF rt 12h 0 
3 LDA THF rt 12h 0 
4 t-BuOK THF rt 12h 0 
5 n-BuLi THF rt 12h 28% 
6 n-BuLi THF -78oC to rt 12h 65% 
7 n-BuLi THF 0oC to rt 8h 49% 
8 EtMgBr THF reflux 24h 54% 
           a purified yield 
To illustrate the generality of this reaction condition, a diverse set of 3-3 (compounds 
3-3a-j in Figure 3.1) was prepared from various compound 3-5 and sodium azide. In 
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all cases, the cycloaddition proceeded smoothly to furnish the heterocyclic fused 
triazoles in high yields.   
We next considered the N-alkylation of the triazole moiety of 3-3 by treating the 
compound with alkyl bromide in a suspension of potassium carbonate and catalytic 
amount of tetrabutyl ammonium iodide in acetone. Theoretically, the alkylation could 
occur on any of the three triazole nitrogens to provide a mixture of 3 isomeric 
products. However N-alkylation of 3-3b with bromocyanomethane or 2-bromo-N-
butyl-acetamide proceeded regiospecifically to give only one product, 3-3n and 3-3p, 
respectively. The NOESY spectra of 3-3n (Figure 3.2) and 3-3p (Figure 3.3) showed 
no interactions between the CH2N of triazole and the CH3 and NCH2 groups on the 6-
membered ring, thus confirming substitution at triazole N-2 position. Analogous N-
alkylations with various compound 3-3 were also performed (compounds 3-3k-t in 
Figure 3.1) and each gave 2-substituted-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one as the 
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3.2.2 Synthesis of substituted pyrrolo[3,4-b]pyridin-2-ones 3-4.  
Pyrroles are commonly obtained via the Barton-Zard condensation between a 
nitroolefin and an alkyl isocyanoacetate22, 23. However, applications of this reaction to 
the preparation of annulated pyrroles are less satisfactory, providing the products in 
low to moderate yield24, 25. Thus in this project, we have investigated the pyrrole 
synthesis via a modified Barton-Zard condensation with heterocyclic vinyl sulfones as 












THF, 0oC to rt, 6h
3-4 (Yield: 85 - 93%)
R1 = Bn, Bu CH2C4H3O; R2 = H, CH3; R3 = H, CH3, Ph, CH(CH3)2
 R5 = Tos, CO2Et,
3-5
 
Scheme 3.4 [3+2] cycloaddition of heterocyclic vinyl sulfones and isocyanide 
 
For the initial evaluation of this reaction, compound 3-5b was treated with p-
toluenesulfonylmethyl isocyanide (TosMIC) in the presence of t-BuOK at room 
temperature to give compound 3-4a in 55% yield. To optimize the reaction, we 
carried out a systematic variation of the reaction time and temperature (Table 3). We 
found that the reaction proceeded more favorably at lower temperatures and 
compound 3-4a was obtained in 86% yield when then reaction was carried out at 0 oC 
and allowed to slowly warm to room temperature in 6 h. The versatility of this 
synthesis was demonstrated with respect to variation in the isocyanide and 
heterocyclic vinyl sulfone by synthesizing a small family of compound 3-4 (Figure 
3.4) in good yields. The NOESY spectra of 3-4e (Figure 3.5) showed the interaction 
of CH3CH2O and NCH2Ph, which indicated that compound 3-4 is the 7-substituted 
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isomer. Further analysis by X-ray crystallography (Figure 3.6) confirmed the 
stereochemical assignments. 
 












Entry 3-5b:B:C Temp. Time Yielda 
1 1:3:3 rt 5h 55% 
2 1:3:3 MW, 62 oC 5 min 21% 
3 1:3:3 0oC to rt 6h 81% 
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Figure 3.5 NOESY spectra of 3-4e 
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In this project, general syntheses of annulated 1,2,3-triazoles and pyrroles have been 
developed. The methods relie on the cycloaddition of 3,4-dihydro-5-sulfonylpyridin-
2-ones 3-5 and affords triazolo[4,5-b]pyridin-5-ones 3-3 and pyrrolo[3,4-b]pyridin-2-
ones 3-4 in good yields and regioselectivity. 
 
3.4 Experimental Section 
3.4.1 General procedures  
All experiments involving moisture or air sensitive were performed under N2 in 
flame-dried glassware capped with a rubber septum. Solid-phase reactions were 
agitated using a Flask shaker SF1 (Stuart Scientific). 
 
3.4.2 Materials 
Analytical grade chemical reagents were purchased from commercial suppliers 
(Aldrich, Fluka, Merck, TCI). The sodium benzenesulfinate resin was purchased from 
Hecheng Co. of Nankai University. All of these compounds were used without further 
purification. Technical ethyl acetate and hexane were distilled before used. Other 
solvents are analytical grade and were used for washing and purification. 
 
3.4.3 Chromatography 
Analytical thin layer chromatography was performed using Merck Kieselgel 60 F254 
pre-coated silica gel glass plate. Visualization of the compounds on the silica gel glass 
plate was carried out by UV illumination and staining with iodine vapor, ninhydrin 
solution or phosphomolybdic acid hydrate solution. Flash column chromatograph was 
performed with silica (Merck, 70-230 mesh) under pressure. 
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3.4.4 Physical data 
1H NMR and 13CNMR spectra were measured at ambient temperature on Bruker DPX 
300 or AMX 500 Fourier Transform spectrometer. Chemical shifts were reported in δ 
(ppm), relative to the internal standard of tetramethylsilane (TMS). And the signals 
observed were described as: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet) and br (broad). The number of protons (n) for a given resonance was 
indicated as nH. All Infra-red (IR) spectra were recorded on a Bio-Rad FTS 165 
spectrometer. Mass spectrometry was performed on a VG Micromass 7035 
spectrometer under EI, ESI or FAB. Crystallography data were collected at room 
temperature using a Siemens R3m/V diffractometer with Mo-Kα radiation (λ = 
0.71060 Å). Lorentz and polarization corrections, structure solution by direct methods, 
full-matrix least-squares refinements and preparation of figures were all performed by 
the SHELXTL-Plus PC program package. All non-hydrogen atoms were refined 
anisotropically whereas hydrogen atoms were placed at calculated positions with 
isotropic displacement coefficient being assigned a value that is 1.6 times that of the 
atom to which it is attached.  
 
3.4.5 Experimental procedures  
General Procedure for the Synthesis of Triazolo[4,5-b]pyridin-5-ones, (3-3a)-(3-
3j). To a solution of the respective compound 3-5 (0.5 mmol) in DMF (15 mL) was 
added sodium azide (2.5 mmol) and the reaction mixture was refluxed for 48 h. 
Thereafter, the reaction mixture was filtered though a small pad of celite, concentrated 




4-Benzyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3a). 1H NMR 
(DMSO-d6, 500MHz): δ 2.80-2.83 (t, 2H, J = 7.6Hz, CH2CH2CO), 2.93-2.96 (t, 2H, J 
= 7.6Hz, CH2CH2CO), 4.94 (s, 2H, NCH2), 7.22-7.31 (m, 5H, ArH), 14.2 (br, 1H, 
NH). 13C NMR (DMSO-d6, 125MHz): δ 16.7, 31.4, 44.8, 127.0, 127.3, 127.7, 128.3, 
137.1, 146.4, 168.2. HRMS (EI) calcd. for C12H12N4O: 228.1011, found: 228.1012.  
 
4-Benzyl-7-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3b). 
1H NMR (DMSO-d6, 500MHz): δ 1.24-1.26 (d, 3H, J = 6.9 Hz, CH3), 2.54-2.59 (m, 
1H, CH2CO), 2.84-2.88 (m, 1H, CH2CO), 3.24-3.28 (m, 1H, CH3CH), 4.89-4.98 (m, 
2H, NCH2), 7.21-7.37 (m, 5H, ArH), 14.2 (br, 1H, NH). 13C NMR (DMSO-d6, 
125MHz): δ  18.6, 24.0, 39.6, 44.9, 125.5, 127.0, 127.3, 128.3, 137.1, 145.6, 168.2 
HRMS (EI) calcd. for C13H14N4O: 242.1168, found: 242.1167. 
 
4-Benzyl-6-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3c). 
1H NMR (DMSO-d6, 300MHz): δ 1.20-1.23 (d, 3H, J = 7.0Hz, CH3), 2.64-2.72 (m, 
1H, CH2CH), 2.84-2.92 (m, 1H, CHCO), 3.09-3.36 (m, 1H, CH2CH), 4.90-5.00 (m, 
2H, NCH2), 7.22-7.32 (m, 5H, ArH), 14.2 (br, 1H, NH). 13C NMR (DMSO-d6, 
75MHz): δ 16.5, 24.6, 36.1, 45.2, 127.0, 127.3, 127.8, 128.3, 137.2, 146.1, 171.1. 
HRMS (EI) calcd. for C13H14N4O: 242.1168, found: 242.1168. 
 
4-Benzyl-7-phenyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3d). 
1H NMR (DMSO-d6, 500MHz): δ 2.93-2.98 (m, 1H, CH2CO), 3.17-3.22 (m, 1H, 
CH2CO), 4.51-4.54 (t, 1H, J = 6.8Hz, CHPh), 4.93-5.05 (m, 2H, NCH2), 7.15-7.31 (m, 
10H, ArH). 13C NMR (DMSO-d6, 125MHz): δ 34.4, 40.1, 45.0, 127.0, 127.1(x2), 
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127.2, 127.4, 128.3, 128.6, 132.9, 141.2, 146.2, 167.7. HRMS (EI) calcd. for 
C18H16N4O: 304.1324, found: 304.1328. 
 
4-Butyl-6,7-dihydro-3H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3e). 1H NMR 
(DMSO-d6, 500MHz): δ 0.86-0.89 (t, 3H, J = 6.9Hz, CH2CH2CH2CH3), 1.24-1.30 (m, 
2H, CH2CH2CH2CH3), 1.52-1.58 (m, 2H, CH2CH2CH2CH3), 2.69-2.72 (t, 2H, J = 
7.6Hz, CH2CH2CO), 2.87-2.90 (t, 2H, J = 7.6Hz, CH2CH2CO), 3.72-3.75 (t, 2H, J = 
7.6Hz, CH2CH2CH2CH3 ), 14.1(br, 1H, NH). 13C NMR (DMSO-d6, 125MHz): δ  13.6, 
16.8, 19.4, 29.1, 31.4, 41.25, 129.9, 146.5, 167.9. HRMS (EI) calcd. for 
C9H14N4O:194.1168, found: 194.1172. 
 
4-Butyl-7-methyl-6,7-dihydro-3H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3f). 
1H NMR (DMSO-d6, 500MHz): δ 0.86-0.88 (t, 3H, J = 7.6Hz, CH2CH2CH2CH3), 
1.21-1.28 (m, 5H, CH2CH2CH2CH3 + CH3), 1.52-1.58 (m, 2H, CH2CH2CH2CH3), 
2.41-2.50 (m, 1H, CH2CO), 2.74-2.78 (m, 1H, CH2CO), 3.15-3.22 (m, 1H, CHCH3), 
3.67-3.79 (m, 2H, CH2CH2CH2CH3 ), 14.1 (br, 1H, NH). 13C NMR (DMSO-d6, 
125MHz): δ 13.6, 18.6, 19.4, 24.0, 29.1, 40.0, 41.2, 134.7, 145.6, 167.8. HRMS (EI) 
calcd. for C10H16N4O: 208.1324, found: 208.1324. 
 
4-Butyl-6-methyl-6,7-dihydro-3H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3g). 
1H NMR (DMSO-d6, 500MHz): δ 0.85-0.90 (t, 3H, J = 7.4Hz, CH2CH2CH2CH3), 
1.15-1.29 (m, 5H, CH2CH2CH2CH3+CH3), 1.50-1.58 (m, 2H, CH2CH2CH2CH3), 
2.56-2.80 (m, 2H, CH2 + CHCH3 ), 3.00-3.08 (m, 1H, CH2), 3.67-3.81 (m, 2H, 
CH2CH2CH2CH3 ), 14.15 (br, 1H, NH). 13C NMR (DMSO-d6, 125MHz): δ 13.6, 16.6, 
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19.4, 24.6, 29.1, 36.0, 41.6, 129.2, 145.2, 170.8. HRMS (EI) calcd. for C10H16N4O: 
208.1324, found: 208.1326. 
 
4-Butyl-7-phenyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, (3-3h). 
1H NMR (DMSO-d6, 500MHz): δ 0.87-0.90 (t, 3H, J = 7.0Hz, CH2CH2CH2CH3), 
1.23-1.31 (m, 2H, CH2CH2CH2CH3), 1.56-1.62 (m, 2H, CH2CH2CH2CH3), 2.83-2.88 
(m, 1H, CH2CO), 3.07-3.12 (m, 1H, CH2CO), 3.75-3.84 (m, 2H, CH2CH2CH2CH3), 
4.46-4.49 (t, 1H, J = 7.0Hz, CHAr), 7.17-7.33(m, 5H, ArH), 14.3(br, 1H, NH). 13C 
NMR (DMSO-d6, 125MHz): δ 13.6, 19.4, 29.1, 34.4, 40.0, 41.3, 125.7, 126.9, 127.0, 




5(4H)-one, (3-3i). 1H NMR (DMSO-d6, 500MHz): δ 1.23-1.24 (d, 3H, J = 6.3Hz, 
CH3), 2.49-2.54 (m, 1H, CH2CO), 2.81-2.85 (m, 1H, CH2CO), 3.19-3.26 (m, 1H, 
CHCH3), 4.89-4.97 (m, 2H, NCH2), 6.26-7.53 (m, 3H, Hfuranyl), 14.25 (br, 1H, NH). 
13C NMR (DMSO-d6, 125MHz): δ 18.6, 24.0, 38.3, 40.0, 107.9, 110.5, 134.6, 142.2, 
145.3, 150.2, 167.9. HRMS (ESI, M-H) calcd. for C11H11N4O2: 232.0882, found: 
232.0880. 
4-(Furan-2-ylmethyl)-6-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-
5(4H)-one, (3-3j). 1H NMR (DMSO-d6, 500MHz): δ 1.18-1.20 (d, 3H, J = 7.0Hz, 
CH3), 2.61-2.67 (m, 1H, CH2CH), 2.79-2.87 (m, 1H, CH), 3.04-3.09 (m, 1H, CH2CH), 
4.88-4.96 (m, 2H, NCH2), 6.24-7.52 (m, 3H, Hfuranyl) 14.2 (br, 1H, NH). 13C NMR 
(DMSO-d6, 125MHz): δ 16.4, 24.6, 36.1, 40.0, 107.8, 110.5, 129.5, 142.2, 145.8, 




General Procedure of the Synthesis of N-Substituted 1,2,3-Triazoles, (3-3k)-(3-3t). 
To a solution of the respective triazole (0.2 mmol) in acetone (5 mL) was added 
potassium carbonate (1 mmol), alkyl bromide (1 mmol) and a catalytic amount of 
N(n-Bu)4I . The reaction mixture was heated to reflux under nitrogen overnight. 




1H NMR (CDCl3, 500MHz): δ 0.85-0.88 (t, 2H, J = 7.6Hz, CH2CH2CH2CH3), 1.22-
1.28 (m, 2H, CH2CH2CH2CH3), 1.76-1.82 (m, 2H, CH2CH2CH2CH3), 2.75-2.78 (m, 
2H, CH2CH2CO), 2.87-2.90 (m, 2H, CH2CH2CO), 4.17-4.20 (t, 2H, CH2CH2CH2CH3), 
4.94 (s, 2H, NCH2Ar), 7.17-7.36 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 13.5, 
17.6, 19.7, 31.7, 32.1, 45.8, 54.5, 127.4, 128.3, 128.6, 130.1, 136.9, 146.7, 168.4. 
HRMS (EI) calcd. for C16H20N4O: 284.1637, found: 284.1643. 
 
2,4-Dibenzyl-6-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, 
(3-3l). 1H NMR (CDCl3, 500MHz): δ 1.24-1.25 (d, 3H, J = 6.9Hz, CH3), 2.54-2.59 (m, 
1H, CH2CH), 2.72-2.78 (m, 1H, CH), 2.97-3.02 (m, 1H, CH2CH), 4.90-4.96 (m, 2H, 
NCH2), 5.34 (s, 2H, NCH2), 7.16-7.33 (m, 10H, ArH). 13C NMR (CDCl3, 125MHz): δ 
16.8, 25.7, 36.9, 46.1, 58.4, 127.4, 127.9, 128.2, 128.3, 128.6, 128.7, 131.0, 135.6, 
137.0, 147.0, 171.4. HRMS (EI) calcd. for C20H20N4O: 332.1637, found: 332.1642. 
 
2,4-Dibenzyl-7-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-5(4H)-one, 
(3-3m). 1H NMR (CDCl3, 500MHz): δ 1.22-1.24 (d, 3H, J = 7.0Hz, CH3), 2.40-2.46 
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(m, 1H, CH2CO), 2.76-2.81 (m, 1H, CH2CO), 3.08-3.15 (m, 1H, CH), 4.89-4.96 (m, 
2H, NCH2), 5.30-5.36 (m, 2H, NCH2), 7.13-7.30 (m, 10H, ArH). 13C NMR (CDCl3, 
125MHz): δ 18.8, 24.9, 40.6, 45.7, 58.4, 127.4, 127.8, 128.1, 128.3, 128.5, 128.6, 




yl)acetonitrile, (3-3n). 1H NMR (CDCl3, 500MHz): δ 1.28-1.30 (d, 3H, J = 7.0Hz, 
CH3), 2.46-2.52 (m, 1H, CH2CO), 2.83-2.88 (m, 1H, CH2CO), 3.16-3.20 (m, 1H, CH), 
4.91-4.98 (m, 2H, NCH2Ph), 5.09 (s, 2H, CH2), 7.17-7.20 (m, 5H, ArH). 13C NMR 
(CDCl3, 125MHz): δ 18.4, 24.9, 40.2, 41.8, 45.9, 112.9, 127.6, 128.3, 128.4, 136.3, 
138.7, 148.0, 168.1. HRMS (EI) calcd. for C15H15N5O: 281.1277, found: 281.1279. 
 
4-Benzyl-7-methyl-2-(2-oxo-2-phenylethyl)-2,4,6,7-tetrahydro-[1,2,3]triazolo[4,5-
b]pyridin-5-one (3-3o). 1H NMR (CDCl3, 500MHz): δ 1.26-1.27 (d, 3H, J = 6.7Hz, 
CH3), 2.44-2.50 (m, 1H, CH2CO), 2.80-2.85 (m, 1H, CH2CO), 3.14-3.22 (m, 1H, CH), 
4.88-4.97 (m, 2H, CH2Ar), 5.59-5.66 (m, 2H, CH2) , 7.12-7.84 (m, 10H, ArH). 13C 
NMR (CDCl3, 125MHz): δ 18.5, 24.9, 40.5, 45.8, 60.0, 127.4, 128.0, 128.2, 128.3, 
128.9, 134.1, 134.2, 136.7, 136.9, 147.0, 168.4, 191.6. HRMS (EI) calcd. for 
C21H20N4O2: 360.1586, found: 360.1588. 
 
2-(4-Benzyl-7-methyl-5-oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[4,5-b]pyridin-2-yl)-
N-butylacetamide, (3-3p). 1H NMR (CDCl3, 500MHz): δ 0.79-0.82 (t, 3H, J = 7.0Hz, 
CH2CH2CH2CH3), 1.14-1.19 (m, 2H, CH2CH2CH2CH3), 1.20-1.30 (m, 5H, 
CH2CH2CH2CH3 + CH3), 2.48-2.53 (m, 1H, CH2CO), 2.85-2.89 (m, 1H, CH2CO),  
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3.08-3.24 (m, 3H, CH2CH2CH2CH3 + CH), 4.86 (s, 2H, NCH2), 4.95 (m, 2H, NCH2), 
5.71 (br, 1H, NH), 7.17-7.32 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 13.6, 18.6, 
19.9, 24.9, 31.3, 39.3, 40.4, 45.7, 57.3, 127.6, 128.3, 128.5, 136.5, 137.2, 147.3, 165.8, 
168.3. HRMS (EI) calcd. for C19H25N5O2: 355.2008, found: 355.2003. 
 
Methyl 2-(4-benzyl-7-methyl-5-oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[4,5-
b]pyridin-2-yl)acetate, (3-3q). 1H NMR (CDCl3, 500MHz): δ 1.27-1.28 (d, 3H, J = 
6.9Hz, CH3CH), 2.46-2.51 (m, 1H, CH2CO), 2.82-2.86 (m, 1H, CH2CO), 3.15-3.22 
(m, 1H, CH), 3.70 (s, 3H, OCH3), 4.93-4.95 (m, 2H, NCH2Ph), 4.98 (s, 2H, NCH2), 
7.15-7.33 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 18.5, 24.9, 40.5, 40.9, 52.7, 
55.1, 127.5, 128.4(x2), 136.7, 137.1, 147.1, 167.6, 168.4. HRMS (M+Na) calcd. for 
C16H18N4NaO3: 337.1277, found: 337.1275. 
 
4-Benzyl-2-(cyclohexylmethyl)-6,7-dihydro-2H-[1,2,3]triazolo[4,5-b]pyridin-
5(4H)-one, (3-3r). 1H NMR (CDCl3, 500MHz): δ 0.86-1.67 (m, 10H, 5CH2), 1.80-
1.86(m, 1H, CH), 2.74-2.90(m, 4H, CH2CH2), 4.00-4.02 (d, 2H, J = 7.6Hz, CHCH2), 
4.94 (s, 2H, NCH2Ph), 7.14-7.36(m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 17.6, 
25.6, 26.2, 30.4, 32.1, 38.6, 45.7, 60.8, 127.4, 128.3, 128.7, 130.0, 136.9, 146.6, 168.4. 
HRMS (EI) calcd. for C19H24N4O: 324.1950, found: 324.1944. 
 
4-Benzyl-2-(cyclohexylmethyl)-6-methyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-
b]pyridin-5(4H)-one, (3-3s). 1H NMR (CDCl3, 500MHz): δ 0.85-1.66 (m, 13H, 5CH2 
+ CH3), 1.81-1.89 (m, 1H, CH), 2.54-2.59 (m, 1H, CH2CHCO), 2.72-2.79 (m, 1H, 
CH2CHCO), 2.97-3.02 (m, 1H, CH2CHCO), 4.00-4.02 (d, 2H, CHCH2), 4.90-4.97 (m, 
2H, NCH2Ph), 7.15-7.35 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 16.8, 25.6, 
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26.2, 29.7, 30.4, 37.0, 38.6, 46.0, 60.8, 127.4, 128.3, 128.6, 129.9, 137.0, 146.3, 171.4. 
HRMS (EI) calcd. for C20H26N4O: 338.2107, found: 338.2105. 
 
4-Benzyl-2-(cyclohexylmethyl)-7-phenyl-6,7-dihydro-2H-[1,2,3]triazolo[4,5-
b]pyridin-5(4H)-one, (3-3t). 1H NMR (CDCl3, 500MHz): δ 0.86-1.64 (m, 10H, 
5CH2), 1.80-1.84 (m, 1H, CH), 2.88-2.93 (m, 1H, CH2CO), 3.04-3.08 (m, 1H, 
CH2CO), 3.98-4.05 (m, 2H, NCH2), 4.28-4.31 (t, 2H, J = 7.0Hz, CHPh), 4.92-5.05 (m, 
2H, NCH2), 7.03-7.35 (m, 10H, ArH). 13C NMR (CDCl3, 125MHz): δ 25.6, 26.2, 30.4, 
35.8, 38.6, 40.9, 45.8, 61.0, 127.1, 127.3, 127.5, 128.3, 128.8, 128.9, 133.0, 136.7, 
140.6, 146.5, 167.8. HRMS (EI) calcd. for C25H28N4O: 400.2263, found: 400.2263. 
 
General Procedure for the Synthesis of Pyrrolo[3,4-b]pyridin-2-ones, (3-4a)-(3-
4l). The respective isocyanide (1.5 mmol) was added to a 1.0 M solution of potassium 
tert-butoxide in THF (1.5 mmol) via a syringe at 0 oC under nitrogen. To this reaction 
mixture at 0oC was added dropwise a solution of the respective vinylsulfone (0.5 
mmol) in dry THF (0.1 M vinylsulfone in THF) and the reaction mixture was stirred 
and allowed to warm slowly to room temperature. The reaction was monitored by 
TLC and was observed to be completed after 6 h. Thereafter, the reaction was 
quenched with saturated aqueous ammonium chloride aqueous solution and extracted 
with ethyl acetate. The combined organic layer was washed with brine (30mL*2), 
dried with MgSO4, concentrated to dryness, and purified by column chromatography. 
 
1-Benzyl-4-methyl-7-tosyl-3,4-dihydro-1H-pyrrolo[3,4-b]pyridin-2(6H)-one, (3-
4a). 1H NMR (DMSO-d6, 500MHz): δ 1.13-1.14 (d, 3H, J = 6.9Hz, CH3CH), 2.28 (s, 
3H, PhCH3), 2.30-2.32 (m, 1H, CH2CO), 2.50-2.58 (m, 1H, CH2CO), 2.89-2.94 (m, 
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1H, CH3CH), 5.08-5.27 (m, 2H, NCH2), 6.77-7.48 (m, 10H, ArH), 11.78 (br, 1H, NH). 
13C NMR (DMSO-d6, 125MHz): 　 18.7, 20.9, 24.5, 40.0, 40.7, 112.8, 118.7, 119.0, 
125.7, 125.8, 126.2, 127.8, 128.0, 129.6, 137.6, 139.4, 143.3, 170.1. HRMS (ESI, M-
H) calcd. for C22H21N2O3S: 393.1273, found: 393.1272. 
 
1-Benzyl-7-tosyl-3,4-dihydro-1H-pyrrolo[3,4-b]pyridin-2(6H)-one, (3-4b). 1H 
NMR (DMSO-d6, 500MHz): δ  2.27 (s, 3H, PhCH3), 2.54-2.57 (t, 2H, J = 7.6Hz, 
CH2CH2CO), 2.67-2.69 (t, 2H, J = 7.6Hz, CH2CH2CO), 5.19 (s, 2H, NCH2), 6.77-
7.46 (m, 10H, ArH), 11.74 (br, 1H, NH). 13C NMR (DMSO-d6, 125MHz): δ 17.5, 
20.9, 32.8, 46.9, 112.7, 113.2, 119.5, 125.5, 125.6, 126.1, 127.9, 129.6, 130.6, 137.5, 
139.4, 143.2, 170.2. HRMS (EI) calcd. for C21H20N2O3S: 380.1195, found: 380.1186. 
 
1-Benzyl-4-isopropyl-7-tosyl-3,4-dihydro-1H-pyrrolo[3,4-b]pyridin-2(6H)-one, 
(3-4c). 1H NMR (DMF-d7, 500MHz): δ 0.79-0.85 (m, 6H, CH3CHCH3), 1.58-1.65 (m, 
1H, CH3CHCH3), 2.33 (s, 3H, PhCH3), 2.49-2.64 (m, 3H, COCH2CH), 5.25-5.30 (m, 
2H, NCH2), 6.93-7.61 (m, 10H, ArH), 11.83 (br, 1H, NH). 13C NMR (DMF-d7, 
125MHz): δ 19.1, 20.5, 21.2, 30.4, 36.4, 37.4, 48.4, 114.2, 117.3, 120.8, 126.8, 127.1, 
127.5, 128.5, 130.5, 131.4, 138.8, 140.8, 144.3, 171.0. HRMS (EI) calcd. for 
C24H26N2O3S: 422.1664, found: 422.1663. 
 
Ethyl 1-benzyl-4-isopropyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-
7-carboxylate, (3-4d). 1H NMR (CDCl3, 500MHz): δ 0.73-0.81 (m, 6H, CH3CHCH3), 
1.18-1.19 (t, 3H, J = 7.0Hz, OCH2CH3), 1.59-1.63 (m, 1H, CH3CHCH3), 2.46-2.61 
(m, 3H, COCH2CH), 4.14-4.18 (m, 2H, OCH2CH3), 5.46 (s, 2H, NCH2),  6.44-6.45 (d, 
1H,  J = 3.2Hz, Hpyrrole), 7.04-7.18 (m, 5H, ArH), 8.91 (br, 1H, NH). 13C NMR 
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(CDCl3, 125MHz): δ 14.3, 18.8, 20.3, 29.7, 36.0, 36.7, 47.0, 60.4, 109.2, 117.1, 117.6, 
126.6, 127.6, 127.9, 132.2, 138.2, 159.4, 171.3. HRMS (EI) calcd. for C20H24N2O3: 
340.1787, found: 340.1788. 
 
Ethyl 1-benzyl-3-methyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-
carboxylate, (3-4e). 1H NMR (CDCl3, 500MHz): δ 1.19-1.20 (m, 6H, CH2CHCH3 + 
OCH2CH3), 2.34-2.38 (m, 1H, CH2CHCH3), 2.62-2.74 (m, 2H, CH2CHCH3), 4.15-
4.19 (m, 2H, OCH2CH3), 5.43-5.55 (m, 2H, NCH2), 6.50-6.51 (d, 1H, J = 3.2Hz, 
Hpyrrole), 7.05-7.19 (m, 5H, ArH), 8.58 (br, 1H, NH). 13C NMR (CDCl3, 125MHz): δ 
14.4, 15.8, 26.0, 37.3, 47.4, 60.5, 109.2, 113.5, 117.1, 126.5, 127.0, 128.1, 132.4, 
138.6, 159.4, 173.9. HRMS (EI) calcd. for C18H20N2O3: 312.1474, found: 312.1465. 
 
Ethyl 1-benzyl-2-oxo-4-phenyl-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-
carboxylate, (3-4f). 1HNMR (CDCl3, 300MHz): δ 1.17-1.22 (t, 3H, J = 7.3Hz, 
OCH2CH3), 2.84-2.87 (m, 2H, CH2CO), 3.98-4.04 (m, 1H, CHPh), 4.14-4.21 (m, 2H, 
OCH2CH3), 5.46-5.58 (m, 2H, NCH2), 6.20-6.21 (d, 1H, J = 6.9Hz, Hpyrrole), 7.03-7.17 
(m, 10H, ArH), 8.84 (br, 1H, NH). 13CNMR (CDCl3, 75MHz): δ 14.3, 36.1, 41.1, 46.7, 
60.5, 109.4, 117.8, 118.0, 126.7, 127.0, 127.4, 127.6, 128.0, 128.6, 131.9, 138.1, 
141.1, 159.4, 170.4.  HRMS (EI) calcd. for C18H20N2O3: 374.1630, found: 374.1643. 
 
Ethyl 1-butyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-carboxylate, 
(3-4g). 1H NMR (CDCl3, 500MHz): δ 0.77-0.82 (t, 3H, J = 7.4Hz, CH2CH2CH2CH3), 
1.15-1.48 (m, 7H, OCH2CH3+CH2CH2CH2CH3), 2.52-2.61 (m, 4H, J = 7.0Hz, 
COCH2CH2), 4.18-4.27 (m, 4H, CH2CH2CH2CH3 + OCH2CH3), 6.56-6.57 (d, 1H, J = 
3.2Hz, Hpyrrole), 8.80 (br, 1H, NH). 13C NMR (CDCl3, 125MHz): δ 13.8, 14.4, 18.1, 
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19.8, 29.7, 33.7, 43.9, 60.4, 109.1, 114.2, 116.9, 132.4, 159.3, 171.2. HRMS (EI) 
calcd. for C14H20N2O3: 264.1474, found: 264.1470. 
 
Ethyl 1-butyl-4-methyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-
carboxylate, (3-4h). 1H NMR (CDCl3, 500MHz): δ 0.85-0.88 (t, 3H, J = 7.6Hz, 
CH2CH2CH2CH3), 1.22-1.29 (m, 5H, CH2CH2CH2CH3 + CH2CHCH3), 1.33-1.36 (t, 
3H, J = 7.0Hz, OCH2CH3), 1.47-1.53 (m, 2H, CH2CH2CH2CH3), 2.28-2.33 (m, 1H, 
CH2CO), 2.62-2.66 (m, 1H, CH2CO), 2.88-2.95 (m, 1H, CH2CHCH3), 4.21-4.34 (m, 
4H, CH2CH2CH2CH3 +OCH2CH3 ), 6.61-6.62 (d, 1H, J = 3.2Hz, Hpyrrole), 8.72 (br, 1H, 
NH). 13C NMR (CDCl3, 125MHz): δ 13.9, 14.5, 19.0, 19.9, 25.0, 29.7, 41.8, 43.8, 
60.5, 109.2, 116.0, 120.4, 131.8, 159.3, 170.9. HRMS (EI) calcd. for C15H22N2O3: 
278.1630, found: 278.1629. 
 
Ethyl 1-butyl-3-methyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-
carboxylate, (3-4i). 1H NMR (CDCl3, 500MHz): δ 0.84-0.87 (t, 3H, J = 7.6Hz, 
CH2CH2CH2CH3), 1.20-1.28 (m, 5H, CH2CH2CH2CH3+COCHCH3), 1.33-1.36 (t, 3H, 
J = 7.0Hz, OCH2CH3), 1.46-1.52 (m, 2H, CH2CH2CH2CH3), 2.35-2.40 (m, 1H, 
CH2CHCO), 2.57-2.64 (m, 1H, COCHCH3), 2.71-2.75 (m, 1H, CH2CHCO), 4.20-
4.32 (m, 4H, CH2CH2CH2CH3 + OCH2CH3 ), 6.61-6.62 (d, 1H, J = 3.2Hz, Hpyrrole), 
8.75 (br, 1H, NH). 13C NMR (CDCl3, 125MHz): δ 13.9, 14.4, 15.7, 19.8, 26.0, 29.8, 
37.3, 44.3, 60.4, 108.9, 113.5, 117.1, 132.3, 159.3, 173.7. HRMS (EI) calcd. for 
C15H22N2O3: 278.1630, found: 278.1633. 
 
Ethyl 1-butyl-2-oxo-4-phenyl-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-7-
carboxylate, (3-4j). 1H NMR (CDCl3, 500MHz): δ 0.78-0.81 (t, 3H, J = 7.6Hz, 
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CH2CH2CH2CH3), 1.16-1.22 (m, 2H, CH2CH2CH2CH3), 1.27-1.30 (t, 3H, J = 7.0Hz, 
OCH2CH3), 1.39-1.46 (m, 2H, CH2CH2CH2CH3), 2.76-2.80 (m, 2H, CH2CO), 3.99-
4.02 (m, 1H, CHPh), 4.18-4.30 (m, 4H, CH2CH2CH2CH3 +OCH2CH3 ), 6.28-6.29 (d, 
1H, J = 3.2Hz, Hpyrrole), 7.14-7.26 (m, 5H, ArH ), 8.75 (br, 1H, NH). 13C NMR 
(CDCl3, 125MHz): δ 13.9, 14.4, 19.9, 29.8, 36.3, 41.3, 44.0, 60.6, 109.2, 117.7, 118.4, 
127.1, 127.4, 128.7, 132.1, 141.4, 159.3, 170.3. HRMS (EI) calcd. for C20H24N2O3: 
340.1787, found: 340.1789. 
 
Ethyl 1-(furan-2-ylmethyl)-4-methyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-
b]pyridine-7-carboxylate, (3-4k). 1H NMR (CDCl3, 500MHz): δ 1.10-1.11(d, 3H, J 
= 6.3Hz, CHCH3), 1.26-1.29 (t, 3H, J = 7.0Hz, OCH2CH3), 2.31-2.34 (m, 1H, 
CH2CO), 2.60-2.64 (m, 1H, CH2CO), 2.81-2.88 (m, 1H, CH), 4.23-4.27 (m, 2H, 
OCH2CH3), 5.50-5.57(m, 2H, NCH2), 6.00-7.14 (m, 4H, Hfuranyl + Hpyrrole), 8.85 (br, 
1H, NH). 13C NMR (CDCl3, 125MHz): δ 14.4, 19.0, 24.8, 39.8, 41.5, 60.5, 107.7, 
109.4, 109.9, 116.0, 120.2, 131.0, 141.6, 151.5, 159.5, 171.0. HRMS (ESI, M+Na) 
calcd. for C16H18N2NaO4: 325.1164, found: 325.1163. 
 
Ethyl 1-(furan-2-ylmethyl)-3-methyl-2-oxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-
b]pyridine-7-carboxylate, (3-4l). 1H NMR (CDCl3, 500MHz): δ 1.18-1.20(d, 3H, J = 
7.0Hz, CHCH3), 1.27-1.30 (t, 3H, J = 6.9Hz, OCH2CH3), 2.30-2.35 (m, 1H, CHCH2), 
2.55-2.70 (m, 2H, CH2CH + CHCH2), 4.23-4.27 (m, 2H, OCH2CH3), 5.47-5.58(m, 
2H, NCH2), 5.98-7.20 (m, 4H, Hfuranyl + Hpyrrole), 8.56 (br, 1H, NH). 13C NMR (CDCl3, 
125MHz): δ 14.4, 15.7, 25.9, 37.3, 40.4, 60.6, 107.5, 109.1, 109.9, 113.5, 117.0, 
131.8, 141.6, 151.8, 159.5, 173.7. HRMS (ESI, M + Na) calcd. for C16H18N2NaO4: 
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Chapter 4  Synthesis and Application of Polymer-supported N-
sulfonyloxaziridine (Davis Reagent) 
 
4.1 Introdcution 
The use of polymer-supported reagents1-5 is a leading strategy in synthesis as it 
combines the advantages of solid-phase chemistry with those of solution phase 
synthesis. In general, a polymer-bound reagent is added in excess to a substrate in 
solution to effect a chemical transformation. At the end of the reaction, the spent 
reagent is removed by simple filtration thus affording the clean product with no need 
for further purification. Furthermore, since both the substrate and product are in 
solution during the reaction, conventional solution phase analytical techniques, such 
as thin-layer chromatography, can be employed for reaction monitoring. The 
versatility of this methodology facilitates the process of library synthesis and has been 
the main stimulus for the recent growth of interest in polymer-supported reagents and 
catalysts. 
 
To-date, various polymer-supported variants of commonly used reagents have been 
prepared and employed in numerous synthetic strategies4, 6-8.  Amongst them, a 
number of oxidants, such as IBX9-10, trimethylamine oxide11, dichromate12, and Swern 
oxidants13, 14 have been developed. However, to the best of our knowledge, the study 
of polymer-supported N-sulfonyloxaziridine has not been explored. N-
Sulfonyloxaziridines (Davis reagent) have been shown to be versatile reagents for the 
oxygenation of a variety of functional group because of their neutral, aprotic, mild 
and stable properties15-22. Nevertheless, the side product of these reactions, N-
sulfonylimine, is easily decomposed to the nonpolar aldehyde and polar sulfonamide 
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which complicates purification23-24. To address the need for a purification-free (mix, 
filter and evaporate) oxidative process with N-sulfonyloxaziridines, we herein present 
the synthesis of soluble polymer-supported N-benzenesulfonyl-3-phenyloxaziridine 4-



























Scheme 4.1 Synthesis of polymer 4-1. 
4.2 Results and discussion 
4.2.1 Synthesis of Polymer-supported N-sulfonyloxaziridine 
The synthesis of polymer 4-1 began with the preparation of 4-vinylbenzaldehyde 4-3. 
This has been previously accomplished using the Wittig reaction25 or through a metal 
catalyzed coupling reaction26-28. However, in this project we sought a new and direct 
procedure for the conversion of 4-2 into 4-3. Hence, we treated 4-2, obtained from the 
hydrolysis of 4-vinylbenzyl chloride29, under various oxidative conditions. It was 
found that the best result was obtained using MnO2 in hexane (Table 4.1, entry 2) and 
the yield obtained was comparable to those obtained in a metal catalyzed coupling 
reaction and was significantly higher than the yield obtained via the Wittig reaction. 
In addition, the reagents used were economical and easy to handle.  
90 
Chapter 4 
Compound 4-3 was subsequently polymerized with styrene using standard AIBN 
initiated radical polymerization methods to afford polymer 4-4 which was amenable 
to KBr FTIR (i.e. the appearance of C=O signal at 1694 cm-1) and 1H NMR analysis. 
From the latter analysis, the styrene/4-3 (m/n) ratio of polymer 4-4 was determined to 
be approximately 4:1, which corresponds to a loading level of ~1.8 mmol/g.   
Table 4.1 Oxidation of 4-2. 
Entry Reagents and Solvent Reaction Conditions Yielda (%) 
1 MnO2 (10 equiv), CH2Cl2 rt, 18 h 73 
2 MnO2 (10 equiv), hexane rt, 18 h 78 
3 MnO2 (10 equiv), ethyl ether rt, 10 h 47 
4 MnO2 (10 equiv), toluene rt, 10 h 67 
5 PCC (1.5 equiv), CH2Cl2 rt, 1.5 h 66 
6 Swern oxidant (3 equiv), CH2Cl2 -78oC, 2 h <5 
a yield of isolated product 
 
With polymer 4-4 in hand, we initially attempted to condense it with 
benzenesulfonamide (Scheme 4.1, route A) under different condition (Table 4.2, 
entries 1-4). However, according to 1H NMR analysis, the conversion was always 
below 50%. This may be attributed to the decomposition of polymer 4-6 during the 
workup process. Since benzenesulfinic acid benzylideneamide is known to be more 
stable than N-benzylidenebenzenesulfonamide and could be instantaneously 
converted to the latter by reaction with m-CPBA35, we decided to synthesize polymer 
4-5 (Scheme 4.1, route B). Different reaction conditions were examined (Table 4.2, 
entries 5-8) and we were pleased to find that using Ti(OEt)4 under microwave 
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irradiation gave 100% conversion within 2 min. Polymer 4-5 was subsequently 
oxidized directly to polymer 4-1 using m-CPBA/KOH. The loading of polymer 4-1 
was determined by 1H NMR and elemental analysis to be ~1.6 mmol/g. 
Table 4.2 Condensation of Polymer 4-5 with Benzenesulfonamide. 
Entry Solvent Catalyst Time Temp. (oC) % conversion
1 toluene Amberlyst 15a 24 h reflux 40 
2 toluene TsOHb 24 h reflux 20 
3 CH2Cl2 TiCl4c 24 h reflux 30 
4 CH2Cl2 TFAAd 24 h reflux 20 
5 CH2Cl2 CsCO3 (2 equiv)e 24 h 40oC 50 
6 CH2Cl2 Ti(OEt)4 (5 equiv)f 12 h 40oC 100 
7 CH2Cl2 Ti(OEt)4 (5 equiv) 1 min 110oC (MW) 90 
8 CH2Cl2 Ti(OEt)4 (5 equiv) 2 min 110oC (MW) 100 
a reference 18 
b reference 30 
c reference 31 
d reference 32 
e reference 33 
f reference 34 
 
4.2.2 Oxidation of sulfides and selenides 
 Sulfoxides are valuable synthons in organic synthesis and are commonly prepared by 
the oxidation of sulfides. The reagents available for such oxidations are varied as 
many of the oxidants are too reactive, resulting in the oxidation of sulfoxide to 
sulfone36-42. Davis and coworkers43 have earlier reported that N-sulfonyloxaziridines 
are able to quantitatively and selectively oxidize sulfides to sulfoxides. With polymer 
4-1 in hand, we proceeded to examine it in such reactions using diphenyl sulfide 4-7a 
(Scheme 4.2).  The yield of diphenyl sulfoxide 4-8a obtained using 4-1 (98%) was 
slightly higher than the solution phase oxidation (93%) and with 4-1 allowed for 
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much easier product isolation.  However with 4-1, the reaction required 12 h to reach 
completion versus 2 h for the solution phase oxidation. Thus, in order to optimize the 
reaction using 4-1, we screened various solvents and found it to be dependent on 
solvent, concentration and temperature (Table 4.3). Amongst the solvents screened, 
CHCl3 was the best solvent and at a concentration of 0.20 M, the reaction was 
completed within 7 h. Further increasing the concentration resulted in a very sticky 
reaction mixture which prevented proper agitation of the reaction mixture. 








Entry Solvent Concentration of 1a Temp. Time Yieldb (%)
1 CHCl3 0.05 M rt 12 h 98 
2 CH2Cl2 0.05 M rt 12 h 92 
3 THF 0.05 M rt 72 h 95 
4 toluene 0.10 M rt 48 h 85 
5 CHCl3 0.10 M rt 10 h 97 
6 CHCl3 0.15 M rt 8 h 98 
7 CHCl3 0.20 M rt 7 h 99 
8 CHCl3 0.10 Mc rt 8 h 90
9 CHCl3 0.10 M 60 oC (MW) 30 min 65d
10 CHCl3 0.10 M 110 oC (MW) 30 min 77d
11 CHCl3 0.10 M 150 oC (MW) 30 min 50d
a ratio of 4-7a to 4-1 is 1:1.1   
b yield of isolated product 
c ratio of 4-7a to 4-1 is 1:1.5 
d TLC showed an incomplete reaction  
 
To demonstrate the applicability of 4-1 to the oxidation of other sulfides, 10 other 
substrates were tested using the reaction conditions listed in Table 4.3, entry 6 and the 
results obtained showed that, in general, both aromatic and aliphatic substrates could 
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be oxidized to the corresponding sulfoxides in excellent yields (Table 4.4, entries 2-
11). In addition, we have also demonstrated (Table 4.4, entry 12) that C-sulfone 4-8m 
could also be synthesized by S-alkylation of lithium arenesulfinate 4-8l which was in 
turn readily prepared from p-thiocresol and polymer 4-1.  
Table 4.4 Oxidation of sulfides using 4-1. 
















































































































4-8l                4-8m 
85c 
 a yield of isolated product  
 b solution phase reaction yield as reported in reference 43 
c yield of 4-8m. Compound 4-8l could not be obtained in a pure form and thus was alkylated 
with bromoacetonitrile to give 4-8m 
 
The syn-elimination of selenoxides to provide alkenes is an important transformation 
that is commonly used in the preparation of complex organic molecules44-46. Hence 
we next explored the use of 4-1 in selenide oxidation using compounds 4-9a and 4-9b 
as examples (Table 4.5). As observed in the solution phase selenide oxidation, 
addition of polymer 4-1 resulted in an instantaneous change in color of the reaction 
mixture from pale yellow to orange. The oxidation was found to be completed within 
20 min and the selenoxides formed were thermolyzed in-situ to afford the unsaturated 
compounds 4-10a and 4-10b respectively. The reaction gave good yields and 
stereoselectivity with only the E-isomer being formed. 






























     a yield of isolated product  




4.2.3 Oxidation of amines and phosphines 
 Oxidation of amines with N-sulfonyloxaziridines has been previously studied and 
found to give products that were dependent upon the structure of the amine47. To 
examine the utility of polymer 4-1 in these oxidative reactions, we initially carried out 
the reaction using the solution phase condition47 and treated tribenzylamine 4-11a 
with 4-1 (1.1 equiv) in CH2Cl2 at room temperature. The reaction required 5 h to 
proceed to completion and tribenzylamine N-oxide 4-12a was obtained in 98% yield. 
Since the same reaction in solution phase gave 4-12a (Table 4.6, entry 1) within 1 h, 
we decided to search for a more efficient procedure for this reaction. Incidentally, we 
discovered that when the reaction was carried out with 0.1 M of polymer 4-1 (2 equiv) 
in CH2Cl2, the oxidation was completed within 4 h and increasing polymer 4-1 to 5 
equivalence shortened the reaction time to 2 h. Encouraged by this result, we 
examined amine oxidation reaction with various amines using the latter reaction 
condition and obtained very good yield in all cases (Table 4.6). 










4-11 4-12  





























































                            a yield of isolated product  
         b solution phase reaction yield 
 
Similarly, we have also employed polymer 4-1 to the oxidation of trivalent 
phosphorous compounds. Reaction optimization (Table 4.7) using triphenylphosphine 
4-13a showed that the reaction proceeded readily with 0.1 M of polymer 4-1 (2 equiv) 
in THF to give triphenylphosphine oxide 4-14a in quantitative yield. A number of 
other phosphines were examined and gave essentially the same results as 
triphenylphosphine on oxidation (Table 4.8) 
 








Entry Equivalence of 4-1 Solvent Time Yielda (%) 
1 1.1 CH2Cl2 12 h 95 
2 1.1 CHCl3 16 h 94 
3 1.1 toluene 16 h 96 
4 1.1 THF 8 h 96 
5 2.0 THF 1.5 h 99 
6 5.0 THF 1 h 99 





































































                            a yield of isolated product  
         b yield obtained from solution phase reaction at room temperature for 0.5 h 
 
4.2.4 Oxidation of enolates and enamines 
 α-Hydroxy carbonyl moieties are key structural units in various natural products and 
useful auxiliaries in chemical synthesis. Earlier works have demonstrated that 
enolates and enamines could be oxidized by N-sulfonyloxaziridines to α-hydroxy 
ketones and α-amino ketones respectively in moderate to good yields.23,48 To explore 
the application of 4-1  in enolate oxidation reaction, we proceeded to prepare benzoin 
4-16a according to the solution phase protocol23 (Table 4.9, entry 1). However it was 
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noted that at -78oC, the reaction mixture was too viscous to allow proper agitation. 
This may be attributed to the low solubility of 4-1 at low temperatures. Hence, we 
repeated the reaction with a lower concentration of 4-1 (Table 4.9, entry 2) and the 
yield obtained (83%) exceeds that from solution phase oxidation (75%). To examine 
the versatility of this reaction, 3 other enolates were employed (Table 10, entries 1-3). 
None of the enolate oxidations using 4-1 resulted in overoxidation and the formation 
of α-dicarbonyl compounds. Furthermore with imide 4-15c, the enolate oxidation 
occurred diastereoselectively to afford only isomer 4-16c.  
Table 4.9 Oxidation of deoxybenzoin with 4-1. 
O 2) 4-1 (1.5 equiv), THF, -78oC, 5h O
OH
1) THF, KHMDS, -78oC, 30min
4-16a4-15a  
Entry Concentration of 4-1 Time Yielda (%) 
1 0.048 M 10 h 35b (75c) 
2 0.015 M 5 h 83 
        a yield of isolated product 
          b TLC showed an incomplete reaction 
                       c solution phase reaction yield as reported in reference 23 
 
For the enamine oxidation, 1-(1,2-diphenyl-vinyl)-pyrrolidine 4-15e, prepared by 
standard methods using TiCl449, was treated with polymer 4-1 (1.1 equiv) in CHCl3 at 
ambient temperature for 6 h to give 1,2-diphenyl-2-pyrrolidinylethanone 4-16e (Table 










Table 4.10 Enolate and enamine oxidation with 4-1. 













































                            a yield of isolated product 
         b solution phase reaction yield as reported in reference 23 
                      c solution phase reaction yield as reported in reference 50 
         d solution phase reaction yield as reported in reference 48 
                                  e yield of isolated product when the reaction was carried out with polymer 4-1 in THF for 
6 h 
 
4.2.5 Oxidative rearrangement  
In 2007, Lovely and co-workers22 reported the effective oxidative rearrangement of 
tetrahydrobenzimidazoles with N-sulfonyloxaziridines to spiro fused 5-imidazolones. 
To identify additional applications of 4-1, we first carried out a solution phase 
oxidative rearrangement with tetrahydrobenzimidazole 4-17a and N-benzenesulfonyl-
3-phenyloxaziridine at room temperature for 5 h and obtained 4-18a in 70% yield. 
Next, we proceeded to use 4-1 in the same reaction using tetrahydrobenzimidazoles 4-
17a and 4-17b. Both compounds underwent smooth rearrangement to the 










4-18a    R=Bn, Yield = 62%
4-18b    R=Me, Yield = 61%
4-17






4.2.6 Recycling of 4-1 
The reduced product of the oxygen transfer reaction with polymer 4-1 is polymer 4-6 
which in some oxidative reactions would partially decompose to polymer 4-4. The 
presence of these products can be easily determined by 1H NMR. When only polymer 
4-6 was present, reoxidation was carried out with m-CPBA/KOH (Scheme 4.2). 
However, if polymer 4-4 was detected, the consumed 4-1 was treated with 
benzenesulfinamide followed by m-CPBA/KOH. We found that careful repetitive 
regeneration of the consumed 4-1 could provide a restored loading level of 1.3-1.6 
mmol/g.  


















To determine the oxidative activity of the regenerated 4-1, three oxidation reactions 
(4-7a to 4-8a, 4-9a to 4-10a, and 4-13a to 4-14a) were selected to demonstrate the 
recycling possibility. Gratifyingly, the regenerated 4-1 was indistinguishable from 
polymer 4-1 and only showed a slow decline in oxidative activity after multiple 







Table 4.11 Recycling versus oxidative activity of 4-1. 









































In conclusion, we have developed a new and direct synthesis of aldehyde 4-3 and 
used it to prepare the first polymer-supported N-benzenesulfonyl-3-phenyloxaziridine, 
4-1.  Polymer 4-1 proved to be a potent oxidant, effecting clean and selective 
oxidation of sulfides, selenides, amines, phosphines and enolates with high yields and 
simple workup.  It also enabled tetrahydrobenzimidazoles to be oxdatively rearranged 
to spiro fused 5-imidazolones  
 
4.4 Experimental Section 
4.4.1 General procedures  
All experiments involving moisture or air sensitive were performed under N2 in 
flame-dried glassware capped with a rubber septum.  
 
4.4.2 Materials 
Analytical grade chemical reagents were purchased from commercial suppliers 
(Aldrich, Fluka, Merck, TCI). All of these compounds were used without further 
purification. Technical ethyl acetate and hexane were distilled before used. Other 
solvents are analytical grade and were used for washing and purification. 
 
4.4.3 Chromatography 
Analytical thin layer chromatography was performed using Merck Kieselgel 60 F254 
pre-coated silica gel glass plate. Visualization of the compounds on the silica gel glass 
plate was carried out by UV illumination and staining with iodine vapor, ninhydrin 
solution or phosphomolybdic acid hydrate solution. Flash column chromatograph was 
performed with silica (Merck, 70-230 mesh) under pressure. 
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4.4.4 Physical data 
1H NMR and 13CNMR spectra were measured at ambient temperature on Bruker DPX 
300 or AMX 500 Fourier Transform spectrometer. Chemical shifts were reported in δ 
(ppm), relative to the internal standard of tetramethylsilane (TMS). And the signals 
observed were described as: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet) and br (broad). The number of protons (n) for a given resonance was 
indicated as nH. All Infra-red (IR) spectra were recorded on a Bio-Rad FTS 165 
spectrometer. Mass spectrometry was performed on a VG Micromass 7035 
spectrometer under EI, ESI or FAB. Crystallography data were collected at room 
temperature using a Siemens R3m/V diffractometer with Mo-Kα radiation (λ = 
0.71060 Å). Lorentz and polarization corrections, structure solution by direct methods, 
full-matrix least-squares refinements and preparation of figures were all performed by 
the SHELXTL-Plus PC program package. All non-hydrogen atoms were refined 
anisotropically whereas hydrogen atoms were placed at calculated positions with 
isotropic displacement coefficient being assigned a value that is 1.6 times that of the 
atom to which it is attached.  
 
4.4.5 Experimental procedure  
Synthesis of 4-vinylbenzaldehyde (4-3) 
4-vinylbenzylalcohol 4-2 was prepared according to a literature procedure29.  
To a solution of 4-2 (1.34 g, 10 mmol) in hexane (50 mL) was added activated MnO2 
(8.70 g, 100 mmol). The mixture was stirred at room temperature for 18 h. When the 
starting material has been completely consumed (monitored by TLC analysis), the 
mixture was filtered through Celite and the filter cake was washed with CH2Cl2 (100 
mL). The combined filtrate and washing was concentrated and purified by column 
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chromatograph to afford 4-3 (1.03g, 78% yield) was a colorless oil. 1H NMR 
(acetone-d6, 300MHz): δ 5.42-5.46 (d, 1H, J = 11.2Hz, CH2=CH), 5.99-6.05 (d, 1H, J 
= 17.8Hz, CH2=CH), 6.81-6.91 (d, 1H, J = 10.8Hz, J = 17.4Hz, CH2=CH), 7.67-7.70 
(d, 2H, J = 8.0Hz, ArH), 7.88-7.91 (d, 2H, J = 8.4Hz, ArH), 10.0 (s, 1H, CHO). 13C 
NMR (acetone-d6, 75MHz): δ 117.4, 127.3, 130.3, 136.6, 136.7, 143.8, 192.0. HRMS 
(EI) cacld. for C9H8O: 132.0575, found: 132.0570. 
 
Synthesis of polymer-supported benzaldehyde (4-4) 
To a mixture of styrene (0.92 mL, 8 mmol) and 4-3 (0.264 g, 2 mmol) in toluene (20 
mL) was added AIBN (0.016 g, 0.1 mmol). The reaction mixture was purged with 
argon for 30 mins and then heated at 70 oC for 48h. Thereafter, the solution was 
concentrated and the resulting residue was dissolved in THF (8 mL) and added slowly 
into vigorously stirred cold CH3OH (0 °C, 80 mL). The resulting suspension that 
formed was filtered by suction filtration to afford polymer 4-4 (0.89 g, 81% yield) as 
a white powder. Loading calcd. by 1H NMR: 1.64 mmol/g. 1H NMR (CDCl3, 
500MHz): δ 1.41-1.82 (d, H2O + -CH2CH-), 6.56-7.52 (m, 21H, ArH), 9.89 (s, 1H, 
CHO). IR (KBr)/cm-1: 3028, 2919, 1694, 1594, 1444, 1206, 1167, 1018. 
 
Synthesis of polymer-supported N-benzylidenebenzenesulfinamide (4-5) 
Racemic benzenesulfinamide was synthesized according a literature procedure51.  
To a solution of 4-4 (2 mmol) and benzenesulfinamide (0.423 g, 3 mmol) in dry 
CH2Cl2 (20 mL) was added Ti(OEt)4 (2.280 g, 10 mmol).  The reaction mixture was 
heated at 40 oC for 12h or under microwave irradiation at 110oC for 2 min and 
subsequently quenched by the addition of CH2Cl2 (80 mL) and H2O (4 mL) . The 
turbid solution that formed was filtered through Celite and the filter cake was washed 
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with CH2Cl2 (50 mL*2). The combined filtrate and washings was concentrated and 
the resulting residue was dissolved in THF (8 mL) and added slowly into vigorously 
stirred cold CH3OH (0 °C, 80 mL). The resulting suspension was filtered by suction 
filtration and dried to afford polymer 4-5 (90-95% yield) as a white powder. 1H NMR 
(CDCl3, 500MHz): δ 1.39-1.80 (m,  H2O + -CH2CH-), 6.50-7.78 (s, 27H, ArH), 8.66 
(s, 1H, CH). IR (KBr)/cm-1: 3057, 3024, 2850, 1595, 1560, 1489, 1446, 1357, 1099, 
1022. 
 
Synthesis of polymer-supported N-sulfonyloxaziridine (4-1). 
Dry m-CPBA (0.345 g, 2 mmol) was added to a solution of 4-5 (1.00 mmol) in 
CH2Cl2 (10 mL). The reaction mixture was stirred at room temperature for 1 h. 
Thereafter, the reaction mixture was added to a white suspension of m-CPBA (0.379 
g, 2.2 mmol) and powdered KOH (0.259 g, 4.62 mmol) in 20 mL of CH2Cl2 (this m-
CPBA/KOH suspension was previously prepared and maintained for 1h at room 
temperature) and stirred for another 1 h. The reaction mixture was then filtered though 
Celite and the filter cake was washed with CH2Cl2 (30 mL*5). The combined filtrate 
and washings was concentrated and the resulting residue was dissolved in CH2Cl2 (8 
mL) and added slowly into vigorously stirred cold CH3OH (0 °C, 80 mL). The 
resulting suspension was filtered by suction filtration and dried in high vacuum 52 to 
afford polymer 4-1 (90-95% yield) as a white powder. Loading calcd. by 1H NMR: 
1.67 mmol/g and elemental analysis: 1.59mmol/g. 1H NMR (CDCl3, 500MHz): δ 
1.39-1.77 (m, H2O + -CH2CH-), 5.40 (s, 1H, CH), 6.48-8.07 (m, 24H, ArH).  IR 





General procedure for sulfide oxidation by 4-1 
To a solution of the respective sulfide (0.2 mmol) in dry CH2Cl2 (1.1 mL) was added 
4-1 (0.22 mmol). The reaction was stirred at room and monitored by TLC. When the 
reaction was completed, the reaction mixture was precipitated in ice-cold methanol 
(20 mL) and the suspension that formed was filtered through filter paper and the filter 
cake was washed by cold methanol (10 mL*3). The combined filtrate and washing 
was concentrated to 2-3 mL and filtered though a Minisart® single use syringe filter 
(pore size 0.2µm) to remove any residual polymer.  The filtrate was concentrated to 
afford the respective sulfoxide 4-8. Only compound 4-8i required further purification 
by simple column chromatography.  
 
1-(Phenylsulfinyl)benzene (4-8a) 
1H NMR (CDCl3, 500MHz): δ 7.42-7.65 (m, 10H, ArH). 13C NMR (CDCl3, 125MHz): 
δ 124.7, 129.3, 131.0, 145.6. HRMS (ESI, M + Na) cacld. for C12H10NaOS: 225.0350, 
found: : 225.0350. 
 
1-(Methylsulfinyl)benzene (4-8b) 
1H NMR (CDCl3, 500MHz): δ 2.70 (s, 3H, CH3), 7.48-7.64 (m, 5H, ArH). 13C NMR 
(CDCl3, 125MHz): δ 43.8, 123.4, 129.3, 131.0, 145.5. HRMS (EI) cacld. for C7H8OS: 
140.0296, found: 140.0293. 
 
1-(Allylsulfinyl)benzene (4-8c) 
1H NMR (CDCl3, 500MHz): δ 3.47-3.58 (m, 2H, CH=CH2), 5.16-5.32 (m, 2H, CH2), 
5.60-5.67 (m, 1H, CH=CH2), 7.47-7.60 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 
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60.8, 123.8, 124.3, 125.2, 129.0, 131.0, 142.8. HRMS (EI) cacld. for C9H10OS: 
166.0452, found: 166.0451. 
 
1-(Benzylsulfinylmethyl)benzene (4-8d) 
1H NMR (CDCl3, 500MHz): δ 3.87-3.94 (m, 4H, 2CH2), 7.28-7.40 (m, 10H, ArH). 
13C NMR (CDCl3, 125MHz): δ 57.2, 128.4, 128.9, 130.0, 130.1. HRMS (EI) cacld. 
for C14H14OS: 230.0765, found: 230.0766. 
 
2-(Methylsulfinyl)naphthalene (4-8e) 
1H NMR (CDCl3, 500MHz): δ 2.78 (s, 3H, CH3), 7.56-7.98 (m, 6H, ArH), 8.20 (s, 1H, 
ArH ). 13C NMR (CDCl3, 125MHz): δ 43.7, 119.4, 124.0, 127.3, 127.7, 128.0, 128.5, 




1H NMR (CDCl3, 500MHz): δ 2.87-2.92 (m, 1H, CH2), 3.11-3.16 (m, 1H, CH2), 3.75-
4.01 (m, 1H, CH2), 4.13-4.19 (m, 1H, CH2), 7.48-7.63 (m, 5H, ArH). 13C NMR 
(CDCl3, 125MHz): δ 56.8, 58.6, 123.9, 129.4, 131.2, 143.0. HRMS (FAB, M + H) 
cacld. for C8H11O2S: 171.0480, found: 171.0482. 
 
3-(Allylsulfinyl)prop-1-ene (4-8g) 
1H NMR (CDCl3, 500MHz): δ 3.38-3.55 (m, 4H, 2CH2), 5.38-5.47 (m, 4H, 
2CH2=CH), 5.85-5.94 (m, 2H, 2CH=CH2). 13C NMR (CDCl3, 125MHz): δ 54.2, 





1H NMR (CDCl3, 300MHz): δ 0.93-0.96 (t, 6H, J = 7.6Hz, 2CH3), 1.40-1.53 (m, 4H, 
2CH2), 1.70- 1.76 (m, 4H, 2CH2), 2.58-2.70 (m, 4H, 2CH2). 13C NMR (CDCl3, 
75MHz): δ 13.6, 22.0, 24.6, 52.1. HRMS (FAB, M + H) cacld. for C8H19OS: 
163.1157, found: 163.1148. 
 
Thian-4-one S-oxide (4-8i) 
1H NMR (CDCl3, 300MHz): δ 2.50-2.58 (m, 2H, CH2), 2.82-2.92 (m, 2H, CH2), 3.26-
3.38 (m, 4H, 2CH2). 13C NMR (CDCl3, 75MHz): δ 32.2, 47.3, 204.6. HRMS (FAB, 
M + H) cacld. for C5H9O2S: 133.0318, found: 133.0322. 
 
4-(Methylsulfinyl)benzaldehyde (4-8j) 
1H NMR (CDCl3, 300MHz): δ 2.75 (s, 3H, CH3), 7.78-7.80 (d, 2H, J = 8.4Hz, ArH), 
8.00-8.03 (d, 2H, J = 8.0Hz, ArH). 13C NMR (CDCl3, 75MHz): δ 43.7, 124.1, 130.3, 
138.0, 152.4, 191.1.  HRMS (FAB, M + H) cacld. for C8H9O2S: 169.0318, found: 
169.0325. 
 
Methyl 2-(furan-2-ylmethylsulfinyl)acetate (4-8k) 
1H NMR (CDCl3, 500MHz): δ 3.54-3.70 (m, 2H, CH2), 3.77 (s, 3H, CH3), 4.16-4.32 
(m, 2H, CH2), 6.38-7.43 (m, 3H, ArH). 13C NMR (CDCl3, 125MHz): δ 50.7, 52.8, 
54.3, 111.2, 112.0, 143.2, 143.8, 165.5. HRMS (FAB, M + H) cacld. for C8H11O4S: 






General procedure for thiolate oxidation by 4-1 
To a cooled (-78 °C) solution of p-thiocresol 4-7l (0.025 g, 0.2 mmol) in THF (10 mL) 
was added dropwise n-BuLi (0.138 mL of a 1.6 N solution in Et2O, 0.22 mmol). After 
stirring the solution at -78 °C for 30 min, a solution of 4-1 (0.4 mmol) in THF (10 mL) 
was added dropwise very slowly. The solution was then stirred at -78 °C for 3 h and 
then slowly warmed to room temperature. The reaction was quenched with H2O (2 
mL). Thereafter, the reaction mixture was concentrated and the resulting residue was 
dissolved in CH2Cl2 (20 mL) and the sulfinate salt 4-8l was extracted with H2O (20 
mL*3). The combined aqueous extracts were washed with CH2Cl2 (20 mL*2), 
concentrated, and dried in the vacuum overnight to provide the crude 4-8l (0.050 g, 
>100%). The crude 4-8l was treated with bromoacetonitrile in DMF at 100 °C for 12h. 
The reaction mixture was concentrated and purified by column chromatography to 
give 4-8m (0.033 g, 85%). 1H NMR (CDCl3, 500MHz): δ 2.49 (s, 3H, CH3), 4.04 (s, 
2H, CH2), 7.44-7.45 (d, J = 8.2Hz, 2H, ArH), 7.90-7.91 (d, J = 8.2Hz, 2H, ArH). 13C 
NMR (CDCl3, 125MHz): δ 21.8, 45.8, 110.5, 128.9, 130.4, 133.7, 146.9.  HRMS (EI) 
cacld. for C9H9NO2S: 195.0354, found:195.0360. 
 
Preparation of selenide4-9 
Selenide 4-9 was prepared according to a literature procedure53.  
1-Phenyl-2-(phenylselenyl)butan-1-one (4-9a) 
1H NMR (CDCl3, 500MHz): δ 0.95-0.98 (t, 3H, J = 7.6Hz, CH3), 1.78-1.87(m, 1H, 
CH2), 1.95-2.04 (m, 1H, CH2), 4.33-4.36(t, 1H, J = 7.0Hz, CH), 7.15-7.81(m, 10H, 
ArH). 13C NMR (CDCl3, 125MHz): δ 12.8, 24.3, 47.7, 127.1, 128.3, 128.4, 128.8, 





1H NMR (CDCl3, 300MHz): δ 0.85-0.90(t, 3H, J = 7.2Hz, CH3), 1.42-1.51(m, 6H, 
3CH2), 1.68-1.83(m, 1H, CH2CH3), 1.95-2.10(m, 1H, CH2CH3), 3.15-3.52(m, 4H, 
2NCH2), 3.79-3.84(dd, 1H, J = 5.9Hz, J = 8.4Hz, CH), 7.16-7.53(m, 5H, ArH). 13C 
NMR (CDCl3, 75MHz): δ 12.8, 24.3, 25.5, 26.2, 26.3, 43.0, 43.2, 47.0, 128.1, 128.3, 
128.8, 135.5, 169.7.   HRMS (ESI, M + H) cacld. for C15H22NOSe:  312.0867, 
found:312.0865. 
 
General procedure for selenide oxidation by 4-1 
To a solution of the respective selenide 4-9 (0.2 mmol) and pyridine (0.08 mL, 1 
mmol) in dry CHCl3 (10 mL) was added 4-1 (0.22 mmol). The reaction mixture was 
stirred at room temperature and monitored by TLC. When the reaction was completed, 
the reaction mixture was concentrated to 1-2 mL. The residue was precipitated in ice-
cold methanol (20 mL), the resulting suspension was filtered through filter paper and 
the filter cake was washed by cold methanol (10 mL*3). The combined filtrate and 
washings was concentrated to 2-3 mL and filtered though a Minisart® single use 
syringe filter (pore size 0.2 µm) to remove any residual polymer.  The filtrate was 
then concentrated to dryness and the residue was dissolved in CH2Cl2 (20 mL) and 
washed by 0.5 N HCl (10 mL*2) and brine (10 mL*2). The solution was concentrated 
and purified by a simple column chromatography to afford 4-10.  
 
(E)-1-Phenylbut-2-en-1-one (4-10a) 
1H NMR (CDCl3, 500MHz): δ 1.98-2.00 (dd, 3H, J = 1.2Hz, J = 6.3Hz, CH3), 6.88-
6.92 (qd, J = 1.2Hz, J = 17.0 Hz, 1H, CH=CHCO), 7.03-7.10 (qd, J = 6.3Hz, J = 
17.0Hz, 1H, CH=CHCO), 7.44-7.92(m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 
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18.5, 127.5, 128.4, 128.9, 132.5, 137.8, 140.5, 190.7. HRMS (EI) cacld. for C10H10O: 
146.0732, found: 146.0728. 
 
(E)-1-(Piperidin-1-yl)but-2-en-1-one (4-10b) 
1H NMR (CDCl3, 500MHz): δ 1.29-1.42(m, 6H, 3CH2), 1.59-1.61(dd, 3H, J = 1.9Hz, 
J = 7.0Hz, CH3), 3.23-3.32 (m, 4H, 2NCH2), 6.01-6.02 (qd, 1H, J = 1.9Hz, J = 
15.2Hz, CH=CHCO), 6.04-6.05(qd, 1H, J = 7.0Hz, J = 15.2Hz, CH=CHCO). 13C 
NMR (CDCl3, 125MHz): δ 17.4, 24.0, 25.0, 26.0, 42.3, 46.1, 121.4, 139.8, 164.7. 
HRMS (EI) cacld. for C9H15NO: 153.1154, found: 153.1150. 
 
General procedure for amine oxidation by 4-1 
To a solution of the respective amine 4-11 (0.2 mmol) in dry CH2Cl2 (10 mL) was 
added 4-1 (1.0 mmol). The reaction was stirred at room and monitored by TLC. When 
the reaction was completed, the reaction mixture was precipitated in ice-cold 
methanol (20 mL) and the suspension that formed was filtered through filter paper 
and the filter cake was washed by cold methanol (10 mL*3). The combined filtrate 
and washings was concentrated to 2-3 mL and filtered though a Minisart® single use 
syringe filter (pore size 0.2µm) to remove any residual polymer.  The filtrate was 
concentrated to afford 4-12. Compound (4-12d)-(4-12f)  were further purified by 
column chromatography. 
 
Tribenzylamine N-Oxide (4-12a) 
1H NMR (CDCl3, 300MHz): δ 3.63 (s, 6H, 3CH2), 7.27-7.49 (m, 15H, ArH). 13C 
NMR (CDCl3, 75MHz): δ 57.9, 126.8, 128.2, 128.7, 139.6. HRMS (ESI, M + H) 




Triethylamine N-oxide (4-12b) 
1H NMR (acetone-d6, 300MHz): δ 1.20-1.25 (t,  9H, J = 7.3Hz, 3CH3), 3.18-3.50 (m, 
6H, 3CH2). 13C NMR (acetone-d6, 75MHz): δ 9.2, 60.2. HRMS (FAB, M + H) cacld. 
for C6H16NO: 118.1232, found:  118.1224. 
 
Tributylamine N-oxide (4-12c) 
1H NMR (CDCl3, 500MHz): δ 0.89-0.92 (t, J = 7.5Hz, 9H, 3CH3), 1.27-1.34 (m, 6H, 
3CH2), 1.61-1.67 (m, 6H, 3CH2), 3.16-3.19 (t, J = 8.2Hz, 6H, 3CH2). 13C NMR 
(CDCl3, 125MHz): δ 13.6, 19.8, 24.7, 64.8. HRMS (ESI, M + H) cacld. for C12H28NO: 
202.2171, found:  202.2165. 
 
N-Benzylidene(phenyl)methanamine N-oxide (4-12d) 
1H NMR (acetone-d6, 300MHz): δ 5.11 (s, 2H, CH2), 7.35-7.58 (m, 8H, ArH), 7.92 (s, 
1H, CH), 8.28-8.31 (m, 2H, ArH). 13C NMR (acetone-d6, 75MHz): δ 72.3, 129.5, 
129.8, 129.9, 130.0, 130.6, 131.2, 133.2, 134.2, 136.5. HRMS (ESI, M + H) cacld. for 
C14H14NO: 212.1070, found: 212.1080. 
 
N-(4-Methoxybenzylidene)benzenamine N-oxide (4-12e) 
1H NMR (CDCl3, 300MHz): δ 3.86 (s, 3H, CH3), 6.94-6.97 (d, 2H, J = 9.1Hz, ArH), 
7.46-7.47 (m, 3H, ArH), 7.71-7.74 (d, 2H, J = 9.1Hz, ArH), 7.87 (s, 1H, CH), 8.35-
8.38 (m, 2H, ArH). 13C NMR (CDCl3, 125MHz): δ 55.6, 114.1, 123.0, 126.4, 128.6, 
129.1, 130.8, 133.6, 134.2, 169.7. HRMS (ESI, M + H) cacld. for C13H11NO: 




3,4-Dihydroisoquinoline N-oxide (4-12f) 
1H NMR (CDCl3, 500MHz): δ 3.09-3.12 (t, 2H, J = 6.9Hz, CH2), 4.02-4.05 (t, 2H, J = 
7.6Hz, CH2), 7.05-7.21 (m, 4H, ArH), 7.68 (s, 1H, CH). 13C NMR (CDCl3, 125MHz): 
δ 27.7, 57.9, 125.4, 127.2, 127.6, 128.3, 129.4, 130.0, 134.1. HRMS (FAB, M + H) 
cacld. for C9H10NO: 148.0757, found:148.0764. 
 
General procedure for phosphine oxidation by 4-1 
To a solution of the respective phosphine 4-13 (0.2 mmol) in dry CH2Cl2 (10 mL) was 
added 4-1 (1.0 mmol). The reaction was stirred at room and monitored by TLC. When 
the reaction was completed, the reaction mixture was concentrated to 1-2 mL and ice-
cold methanol (20 mL) was added. The suspension that formed was filtered through 
filter paper and the filter cake was washed by cold methanol (10 mL*3). The 
combined filtrate and washings was concentrated to 2-3 mL and filtered though a 
Minisart® single use syringe filter (pore size 0.2µm) to remove any residual polymer.  
The filtrate was concentrated to afford 4-14.  
 
Triphenylphosphine oxide (4-14a) 
1H NMR (CDCl3, 500MHz): δ 7.38-7.65 (m, 15H, ArH). 13C NMR (CDCl3, 125MHz): 
δ 128.2, 128.4, 131.7(x2), 131.8, 131.9, 132.0, 132.8. 31P NMR(CDCl3, 202Hz): δ 
29.5. HRMS (ESI, M + H) cacld. for C18H16OP: 279.0939, found: 279.0926. 
 
Diethyl(phenyl)phosphine oxide (4-14b) 
1H NMR (CDCl3, 500MHz): δ 1.04-1.11 (m, 6H, 2CH3), 1.79-2.01 (m, 4H, 2CH2), 
7.43-7.67 (m, 10H, ArH). 13C NMR (CDCl3, 125MHz): δ 5.4 (d, J = 4.5Hz), 22.1 (d, 
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J = 69.2Hz), 128.5, 128.6, 130.4, 130.5, 131.3, 131.4 (X2), 132.0. 31P NMR(CDCl3, 
202Hz): δ 44.4.  HRMS (EI) cacld. for C10H15OP: 182.0861, found: 182.0856. 
 
Cyclohexyldiphenylphosphine oxide (4-14c) 
1H NMR (CDCl3, 500MHz): δ 1.19-2.14 (m, 10H, 5CH2), 2.18-2.45 (m, 1H, CH), 
7.42-7.77 (m, 10H, ArH). 13C NMR (CDCl3, 125MHz): 　 24.7(d, J = 2.7Hz), 25.7, 
26.3 (d, J = 13.6Hz), 37.1 (d, J = 72.0Hz), 126.3, 128.4, 128.5, 128.7, 130.9, 131.0, 
131.3, 131.4, 131.6, 132.3. 31P NMR (CDCl3, 202Hz): δ 35.2. HRMS (FAB, M + H) 
cacld. for C18H22OP: 285.1408, found: 285.1395. 
 
Tri(p-tolyl)phosphine oxide (4-14d) 
1H NMR (CDCl3, 500MHz): δ 2.37(s, 9H, 3CH3), 7.22-7.24 (m, 6H, ArH), 7.51-7.54 
(m, 6H, ArH). 13C NMR (CDCl3, 125MHz): δ 21.5, 129.0, 129.1, 129.2, 130.1, 131.9, 
132.0, 142.0, 142.1. 31P NMR (CDCl3, 202Hz): δ 29.9. HRMS (ESI, M + Na) cacld. 
for C21H21NaOP: 343.1228, found: 343.1231. 
 
Tri(o-tolyl)phosphine oxide (4-14e) 
1H NMR (CDCl3, 500MHz): δ 2.48(s, 9H, 3CH3), 7.07-7.46 (m, 12H, ArH). 13C NMR 
(CDCl3, 125MHz): δ 21.9 (d, J = 3.6 Hz), 125.4, 125.5, 130.1, 131.0, 131.8(x2), 
131.9, 132.0, 132.8, 132.9, 143.4, 143.5. 31P NMR (CDCl3, 202Hz): δ 37.9.  HRMS 







Trifuran-2-ylphosphine oxide (4-14f) 
1H NMR (CDCl3, 500MHz): δ 6.52-7.71 (m, 9H, ArH). 13C NMR (CDCl3, 125MHz): 
δ 110.9, 111.0, 123.3, 123.5, 145.3, 146.6, 148.7, 148.8. 31P NMR(CDCl3, 202Hz): δ  
-11.0. HRMS (ESI, M + Na) cacld. for C12H9NaO4P: 271.0136, found: 271.0140. 
 
Preparation of (R)-4-benzyl-3-heptanoyloxazolidin-2-one 4-15c 
Compound 15c was synthesized according to the literature.50 
1H NMR (CDCl3, 500MHz): δ 0.81-0.84(m, 3H, CH3), 1.22-1.34(m, 6H, CH3 
CH2CH2CH2CH2CH2), 1.58-1.65(m, 2H, CH3CH2CH2CH2CH2CH2), 2.67-2.71(dd, 
1H, J = 9.4Hz, J = 13.2Hz, CH2Ph), 2.78-2.92 (m, 2H, CH3CH2CH2CH2CH2CH2 ), 
3.20-3.23 (dd, 1H, J = 3.8Hz, J = 13.8Hz, CH2Ph), 4.06-4.13(m, 2H, OCH2), 4.57-
4.62(m, 1H, CHBn), 7.12-7.26 (m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 14.0, 
22.4, 24.2, 28.7, 31.5, 35.5, 37.9, 55.1, 66.1, 127.2, 128.9, 129.4, 135.3, 153.4, 173.4. 
HRMS (EI) cacld. for C17H23NO3: 289.1678, found: 289.1678. 
  
General procedure for oxidation of enolates by 4-1 
To a solution of KHMDS (0.60 mL, 0.5M in THF, 0.3 mmol) (for 4-15c NaHMDS 
was used instead) in THF (15 mL) was added the respective 4-15 (0.2 mmol) under 
argon at -78oC. After stirring the reaction mixture at -78oC for 30 mins, 4-1 (0.30 
mmol) in THF (5 mL) was added in one portion. The reaction was monitored by TLC 
and was observed to be completed within 5 h.  The reaction was quenched with 0.5 
mL saturated NH4Cl aqueous solution (0.5 N camphorsulfonic acid in THF was used 
for 4-15c) and concentrated to 1-2 mL. Ice-cold methanol (20 mL) was then added 
and the suspension that formed was filtered through filter paper and the filter cake 
was washed by cold methanol (10 mL*3). The combined filtrate and washings was 
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concentrated to 2-3 mL and filtered though a Minisart® single use syringe filter (pore 
size 0.2µm) to remove any residual polymer.  The filtrate was concentrated and 
purified by a simple column chromatography to give 4-16. 
 
2-Hydroxy-1,2-diphenylethanone (4-16a) 
1H NMR (CDCl3, 300MHz): δ 5.88 (s, 1H, CH), 7.16-7.83 (m, 10H, ArH). 13C NMR 
(CDCl3, 125MHz): δ 76.2, 127.7, 128.5, 128.6, 129.0, 129.1, 133.5, 133.9, 140.0, 
198.9.  HRMS (EI) cacld. for C14H12O2: 212.0837, found: 212.0844. 
 
Methyl 2-hydroxy-2-phenylacetate (4-16b) 
1H NMR (CDCl3, 300MHz): δ 3.51 (s, 1H, OH), 3.76 (s, 3H, CH3), 5.18 (s, 1H, CH), 
7.33-7.43 (m, 5H, ArH). 13C NMR (CDCl3, 75MHz): δ 53.0, 72.9, 126.6, 128.5, 128.6, 
138.2, 174.1.  HRMS (EI) cacld. for C9H10O3: 166.0630, found:166.0629. 
 
(R)-4-Benzyl-3-((S)-2-hydroxyhexanoyl)oxazolidin-2-one (4-16c) 
1H NMR (CDCl3, 500MHz): δ 0.88-0.90(t, 3H, J = 6.9Hz, CH3), 1.28-1.36(m, 4H, 
CH3CH2CH2CH2CH2), 1.49-1.60 (m, 3H, CH3CH2CH2CH2CH2), 1.77-1.84 (m, 1H, 
CH3CH2CH2 CH2CH2),  2.82-2.87 (dd, 1H, J = 9.5Hz, J = 13.2Hz, CH2Ph), 3.30-3.33 
(dd, 1H, J = 3.2Hz, J = 13.9Hz, CH2Ph), 3.41-3.43 (d, 1H, J = 3.2Hz, OH), 4.23-4.30 
(m, 2H, OCH2), 4.64-4.69 (m, 1H, CHOH), 4.97-5.01 (m, 1H, CHBn), 7.20-7.36 (m, 
5H, ArH). 13C NMR (CDCl3, 125MHz): δ 14.0, 22.5, 24.9, 31.4, 34.2, 37.5, 55.5, 66.9, 
70.9, 127.5, 129.0, 129.4, 134.8, 153.1, 175.1. HRMS (EI) cacld. for C17H23NO4: 






1H NMR (CDCl3, 500MHz): δ 0.92-0.95(t, 3H, J = 7.6Hz, CH3), 1.56-1.65(m, 1H, 
CH2), 1.92-1.97 (m, 1H, CH2), 5.04-5.06 (dd, 1H, J = 3.8Hz, J = 6.3Hz, CH), 7.47-
7.91(m, 5H, ArH). 13C NMR (CDCl3, 125MHz): δ 8.8, 28.8, 73.3, 128.4, 128.8, 133.7, 
133.8, 202.0. HRMS (EI) cacld. for C10H12O2:  164.0837, found: 164.0838. 
 
Preparation of 1-(1,2-diphenylvinyl)pyrrolidine 4-15e 
Compound 15e was prepared according to a literature procedure49. 1H NMR (CDCl3, 
500MHz): δ 1.89-1.91 (m, 4H, 2CH2), 3.08-3.10 (t, 4H, J = 7.0Hz, 2NCH2), 5.36 (s, 
1H, CH), 6.67-7.36 (10H, m, ArH). 13C NMR (CDCl3, 125MHz): δ 25.0, 48.6, 99.4, 
122.7, 127.3, 127.6, 127.8, 128.6, 129.6, 138.3, 139.6, 148.4. HRMS (ESI, M + H) 
cacld. for C18H20N: 250.1596, found: 250.1591. 
 
General procedure for oxidation of enamine by 4-1 
To a solution of 4-15e (0.050 g, 0.2 mmol) in dry THF (2.2 mL) was added 4-1 (0.22 
mmol). The reaction was stirred at room and monitored by TLC. When the reaction 
was completed, ice-cold methanol (20 mL) was added and the suspension that formed 
was filtered through filter paper and the filter cake was washed by cold methanol (10 
mL*3). The filtrate and washings was concentrated to 2-3 mL and filtered though a 
Minisart® single use syringe filter (pore size 0.2µm) to remove any residual polymer.  
The filtrate was concentrated and purified by a simple column chromatography to 
afford 4-16e (0.032 g, 62%) . 1H NMR (CDCl3, 500MHz): δ 1.67-1.76 (m, 4H, 2CH2), 
2.34-2.38 (m, 2H, NCH2), 2.57-2.62m, 4H, NCH2), 4.81 (s, 1H, CH), 7.13-7.94 (10H, 
m, ArH). 13C NMR (CDCl3, 125MHz): δ 23.1, 52.6, 76.1, 128.0, 128.3, 128.6, 129.0, 
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129.7, 132.8, 136.1, 136.7, 197.1. HRMS (ESI, M + H) cacld. for C18H20NO: 
266.1545, found: 266.1537. 
 
Preparation of tetrahydrobenzimidazole 4-17 
17 was synthesized according to a literature procedure54. 
1-Benzyl-4,5,6,7-tetrahydro-1H-benzo[d]imidazole (4-17a) 
1H NMR (CDCl3, 500MHz): δ 1.68-1.69(m, 4H, 2CH2), 2.26-2.53(m, 4H, 2CH2), 
4.90(s, 2H, NCH2), 6.99-7.31(m, 6H, ArH). 13C NMR (CDCl3, 125MHz): δ 20.5, 22.9, 
23.2, 24.3, 48.3, 125.7, 126.8, 127.8, 128.8, 135.3, 136.5, 137.1. HRMS (EI) cacld. 
for  C14H16N2: 212.1313, found:212.1304. 
 
1-Methyl-4,5,6,7-tetrahydro-1H-benzo[d]imidazole (4-17b) 
H NMR (CDCl3, 500MHz): δ 1.57-1.84 (m, 4H, 2CH2), 2.46-2.59 (m, 4H, 2CH2), 
3.48 (s, 3H, CH3), 7.30(s, 1H, CH). 13C NMR (CDCl3, 125MHz): δ 20.2, 22.9, 23.2, 
24.2, 30.7, 126.0, 125.4, 136.7.   HRMS (EI) cacld. for C8H12N2: 136.1000, found: 
136.0998. 
 
General procedure for oxidative rearrangement by 4-1 
To solution of the respective tetrahydrobenzimidazole 4-17 (0.2 mmol) in CHCl3 (4 
mL) was added 4-1 (0.4 mmol). The reaction mixture was stirred at room temperature 
for 24h. The reaction mixture was precipitated in 40 mL ice-cooled methanol. The 
suspension was filtered through a filter paper and the filter cake was washed by cold 
methanol (10 mL*3). The combined filtrate and washing was concentrated to 2-3 mL 
and filtered though a Minisart® single use syringe filter (pore size 0.2µm) to remove 
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any residual polymer.  The filtrate was concentrated and purified by a simple column 
chromatography to give 4-18. 
 
3-Benzyl-1,3-diazaspiro[4.4]non-1-en-4-one (4-18a) 
1H NMR (CDCl3, 300MHz): δ 1.71-1.96 (m, 8H, 4CH2), 4.55 (s, 2H, NCH2), 7.14-
7.31 (m, 5H, ArH), 7.45 (s, 1H, CH).  13C NMR (CDCl3, 75MHz): δ 25.8, 37.2, 44.5, 




1H NMR (CDCl3, 500MHz): δ 1.75-1.97(m, 8H, 4CH2), 3.09 (s, 3H, CH3), 7.56 (s, 
1H, CH). 13C NMR (CDCl3, 125MHz): δ 25.8, 27.3, 37.2, 77.7, 152.1, 161.7. HRMS 
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13C NMR Spectra of 4-18a 
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